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Abstract 
This thesis presents a mathematical model of the electric field from im-
plantable defibrillators, together with the numerical implementation, valida-
tion and examples of application of the model. 
The model was based on Laplace's equation for potential and was im-
plemented using the boundary element method with constant quadrilateral 
elements and realistic torso structures. An efficient out-of-core solver was de-
veloped, allowing any size problem to be solved, subject only to computer 
speed and time available. A method was also developed that allowed matrices 
calculated in one problem to be used in other, similar problems, often reducing 
calculation times by an order of magnitude. 
Model validation included comparison of myocardial potentials from the 
model to those from a finite element model (r.e..2.8%) and from measure-
ments in a sheep (c.c.=0.464, r.e..23.6%). Validation was also done against 
resistance and voltage at defibrillation threshold from 29 patients implanted 
with a transvenous system and 8 patients with the transvenous system and an 
additional subcutaneous patch. Without the patch, the relative error between 
the average of the clinical results and the model result was 9.4% (voltage) 
and 0.8% (resistance). The average of the relative errors between each clinical 
result and the model result was 23.4% (voltage) and 11.6% (resistance). With 
the patch, the equivalent relative errors were 33.9%, 19.4%, 44.0% and 22.5%. 
Transvenous, epicardial and subcutaneous electrode configurations were 
modelled in a series of investigations. The best transvenous configuration was 
with a right ventricular cathode and an anode in the inferior vena cava, where 
defibrillation voltage and energy were reduced by 35% and 55%, respectively, 
compared to a standard configuration with the anode in the superior vena 
cava. Configurations with a right ventricular cathode and large epicardial 
patch performed best, though, and reduced voltage and energy by up to 59% 
and 79%, respectively. The optimal length of the right /ventricular transvenous 
electrode was approximately 60mm. An infarcted heart was also modelled. 
For future work, anisotropy may be added to the heart and skeletal muscle 
of the model. Anisotropic regions may be represented by many small boundary 
element regions or by finite elements. Automated construction of the torso 
mesh and an algorithm for automatically optimising electrode position may 
be developed. Individual patients may be modelled and predicted values of 
defibrillation voltage, energy and resistance compared to values measured at 
the time of implantation. 
In conclusion, the boundary element model was successful in modelling the 
electric field in the torso and in predicting implantable defibrillator perfor-
mance. The model has potential to be used in research and development and 
in clinical settings. 
Acknowledgements 
I wish to acknowledge help given by my supervisor, Professor D. Kilpatrick, 
and co-supervisors, Dr. P.R. Johnston and Dr. P.M. Nickolls, and also by Telec-
tronics Pty. Ltd. I wish to acknowledge the work done by Dr. Johnston in 
providing computer code for some numerical integration routines, and pro-
viding geometry data for some torso surfaces used in the Thesis. I am very 
grateful to the support and assistance given by my supervisors. 
I also wish to thank my wife Carol for her support and encouragement 
during the past four years, without which this task would have been much 
more difficult. I would also like to acknowledge the support of my parents and 
my parents in-law, which was much appreciated. 








2.1 Introduction 	  4 
2.2 Heart Structure and Function 	  4 
2.3 Early History of Defibrillation 	  13 
2.4 Implantable Defibrillators 	  14 
2.5 Defibrillator Voltage Waveforms 	  17 
2.6 Glossary 	  18 
3 Literature Review 20 
3.1 Introduction 	  20 
3.2 Modelling 	  20 
3.3 Clinical Results using Implantable Defibrillators 	  34 
3.4 Discussion 	  40 
4 Numerical Methods 42 
4.1 Introduction 	  42 
4.2 Boundary Element Method 	  43 
4.3 Finite Element Method 	  48 
5 Implementation of Numerical Methods 50 
5.1 	Introduction 	  50 
vi 
CONTENTS 	 vii 
5.2 Torso Construction 	  51 
5.3 Boundary Element Method Implementation 	  60 
6 Validation of Numerical Methods 	 67 
6.1 Introduction 	  67 
6.2 Comparison with Analytical Solution for Concentric Spheres 	68 
6.3 Comparison with Finite Element Solution for a Cube 	 71 
6.4 Comparison with Finite Element Solution for Realistic Torso 
and Electrodes 	  72 
7 Validation in Sheep and Humans 	 76 
7.1 Introduction 	  76 
7.2 Sheep Validation 	  77 
7.3 Human Comparison 	  82 
8 Investigations 	 86 
8.1 Introduction 	  86 
8.2 Electrode Types 	  86 
8.3 Electrode Configurations Tested 	  88 
8.4 Performance Calculations 	  99 
8.5 Results 	  104 
8.6 Discussion 	  108 
8.7 Conclusion 	  130 
9 Conclusion 	 131 
A Detail of the Boundary Element Model 	 138 
B Element Integrals 	 149 
C Statistical Definitions 	 152 
D Enguard Electrodes 	 153 
List of Figures 
2.1 Heart structure 	  5 
2.2 The probability curve for defibrillation (from Ideker et al. [1]) . 	 11 
2.3 Example of a common implantable defibrillator system, with a 
pulse generator, transvenous electrodes in the right ventricle 
(RV) and superior vena cava (SVC) and a subcutaneous (SQ) 
patch electrode   16 
2.4 Examples of potential defibrillator waveforms, plotted as volt-
age versus time. Truncated exponential, biphasic and sequential 
waveforms are commonly used with implantable defibrillators. . . 18 
3.1 Minimum energy (mean ± standard deviation) for defibrillation 
in humans for various electrode configurations (data from Ta-
ble 3.3). Dotted line indicates mean energy.   39 
5.1 Slice through the torso showing regions in the model 	 52 
5.2 Components of the human torso discretised into boundary ele- 
ments (also see Plates 1 and 2)   55 
5.3 Components of the sheep torso discretised into boundary elements 56 
5.4 Types of electrodes implemented in the boundary element model. 57 
LIST OF FIGURES 	 ix 
5.5 Cross-section through the (a) first, (b) second, (c) third and 
(d) sixth (and final) brick meshes during construction of the 
finite element torso. On the final brick mesh, bricks outside 
the torso have been removed and the boundary element mesh 
superimposed 	  58 
5.6 Components of the finite element torso 	  59 
5.7 The block structure of matrix A in equation (4.20) 	 61 
5.8 Matrix A and vector b from equation (4.20) after processing 
as far as possible to upper-diagonal form before the transvenous 
electrodes were defined 	  62 
5.9 Procedure for solving equation (4.20) 	  63 
5.10 Normal and tangential components of gradient on a boundary 
element. 	  65 
6.1 Slice through the center of the concentric spheres model 	 69 
6.2 Potential and potential gradient within concentric spheres . . . 	70 
6.3 Finite element meshes (a) coarse, (b) each element split once 
(c) each element split twice. Surface nodes beneath the markers 
	
are set to the potentials indicated.   72 
6.4 FE and BE results for meshes that are progressively refined . . 	73 
6.5 Comparison of FE and BE results for endocardial electrodes in 
the RV and SVC (RE = 2.8%) 	  74 
7.1 Apparatus to recording potentials from sheep 	  78 
7.2 Epicardial potential maps (mV) for experimental and model re- 
sults for endocardial electrodes (50mV signal) in a sheep . . . . 80 
7.3 Correlation of epicardial potentials for experimental and model 
results for endocardial electrodes (50mV signal) in a sheep . . . 81 
7.4 Comparison of defibrillation voltage and resistance from the model 
and from measurements in humans 	  84 
LIST OF FIGURES 	 x 
8.1 Example of a configuration with endocardial electrodes in the 
IVC and RV 	  87 
8.2 Anode at or above the standard position (configuration TA-VS) 	90 
8.3 Anode below the standard position (configuration TA-VS) . . . 	91 
8.4 Pulmonary artery transvenous electrode (configuration TA-PA) 	92 
8.5 Modified transvenous right ventricular electrode (configuration 
EC) 	  93 
8.6 Different length right ventricular electrodes (configuration CL) 	94 
8.7 Epicardial patch pair (configuration EPP) 	  95 
8.8 67cm 2 epicardial patch (configuration EP-T 1) 	  96 
8.9 131cm 2 epicardial patch (configuration EP-T 2) 	  96 
8.10 220cm 2 epicardial patch (configuration EP-T 3) 	  97 
8.11 25cm 2 epicardial patch and large (32cm 2 ) right ventricular elec- 
trode (configuration EP-T 5) 	  98 
8.12 Apical, sub-apical and pectoral subcutaneous patch locations (con- 
figuration SQ) 	  100 
8.13 Left posterior epicardial and anterior subcutaneous patch com- 
bination (configuration SQ 4) 	  101 
8.14 Healthy and infarcted hearts: the infarcted heart was represented 
as having an infarct in the left-anterior wall of the left ventricle 
resulting in myopathy and bulging of the affected region into the 
lung cavity (configuration INF) 	  102 
8.15 Slices through healthy and infarcted hearts (configuration INF) 	 103 
8.16 Configuration TA-VS results showing how the location of the 
transvenous anode affects defibrillation performance with a stan-
dard cathode in the right ventricle. Height was measured to the 
inferior end of the electrode braid  105 
LIST OF FIGURES 	 xi 
8.17 Configuration CL results showing how the length of the cathode 
in the right ventricle effects defibrillation performance with a 
standard anode in the superior vena cava 	  106 
8.18 Potential distribution, cathode & anode 040-020 (TA-VS 1) . . 	 109 
8.19 Potential gradient distribution, cathode & anode 040-020 (TA- 
VS I) 	  110 
8.20 Potential distribution, cathode 85 anode 040-024 (TA-VS 3) . . 	 111 
8.21 Potential gradient distribution, cathode 61 anode 040-024 (TA- 
VS 3) 	  112 
8.22 Potential distribution, cathode & optimal anode in inferior vena 
cava (TA-VS 4) 	  113 
8.23 Potential gradient distribution, cathode & optimal anode in in- 
ferior vena cava (TA-VS 4) 	  114 
8.24 Potential distribution, cathode, anode 040-020 and apical sub- 
cutaneous patch (TA-SQ 1) 	  115 
8.25 Potential gradient distribution, cathode, anode 040-020 and api- 
cal subcutaneous patch (TA-SQ 1) 	  116 
8.26 Potential distribution, transvenous cathode and pulmonary artery 
anode (TA-PA 1) 	  117 
8.27 Potential gradient distribution, transvenous cathode and pul- 
monary artery anode (TA-PA I) 	  118 
8.28 Potential distribution, epicardial patch pair (EPP) 	  119 
8.29 Potential gradient distribution, epicardial patch pair (EPP) . . 	 120 
8.30 Potential distribution, transvenous cathode and epicardial patch 
anode (EP-T I) 	  121 
8.31 Potential gradient distribution, transvenous cathode and epicar- 
dial patch anode (EP-T I) 	  122 
LIST OF FIGURES 	 xii 
8.32 (a) efficient 'myocardial sandwich' configuration where the volt-
age and energy is dissipated entirely within the myocardium (b) 
less efficient standard configuration with additional voltage and 
energy dissipation within other parts of the thorax   129 
D.1 Enguard ventricular electrode 	  153 
D.2 Enguard ventricular electrode-tip detail 	  154 
D.3 Enguard Standard Atrial Lead 040-020 	  155 
D.4 Enguard Atrial Lead 040-022 	  156 
D.5 Enguard Atrial Lead 040-024 	  157 
List of Tables 
3.1 Internal defibrillation simulation results (from Kinst et al. [2]). 
Epicardial patch pairs were: 54cm 2 conformal (epi-conform), 
32crn 2 (epi-32) and 16cm 2 (epi-16). RV-10, RV-5 and SVC-5 
designate location and length (in cm) of endocardial electrodes 
and SQ was a 25cm 2 subcutaneous patch. Energy was derived 
assuming 1501F capacitor and 7ms pulse.   27 
3.2 Reported values of conductivity ('1' is longitudinal, 't' is trans- 
verse)    31 
3.3 Reported performance of electrode configurations in humans. RA 
= right atrium, RV = right ventricle, SVC = superior vena cava, 
AC = active can pulse generator, SQ = subcutaneous patch (with 
subscript indicating location), CS = coronary sinus and (s) = stored 
energy. Energy data from this data is plotted in Figure 3.1. p values 
are between value on row and values below and/or above. p=NS for 
resistance.   35 
5.1 Values of resistivity (Qcm) used in the model. 	  54 
6.1 Results from the concentric sphere model 	  69 
7.1 Relative error (7 0) (RE) between clinical and model results for 
configurations with endocardial electrodes in the right ventricle 
(RV) and superior vena cava (SVC) and an apical subcutaneous 
patch (SQ)   85 
8.1 Results of investigations for different electrode configurations in 
the human torso boundary element model. Results are for the 
resistance between the electrodes, electrode voltage, energy dis-
sipated in the torso and the maximum voltage gradient in the 
ventricular myocardium. Results were calculated for defibrilla-
tion using a 150/1F capacitor and a mono phasic 7ms pulse with 
a minimum voltage gradient in the ventricular myocardium of 
5V/cm   107 
Right lung 
Chest 
















Plate 1: Components of the boundary element human torso-exploded 
Plate 2: Components of the boundary element human torso-in situ 
Plate 3: Standard transvenous electrode configuration within heart (anode is 
red, cathode is white) 
Plate 4: Potential and potential gradient on a section through the ventricles. 
The electrode voltage (447V) was just sufficient for defibrillation, resulting in 
a potential gradient of at least 5V I cm everywhere within the ventricular 
myocardium. 
Potential gradient on heart 
75 
(VCM)L, 5 






Plate 5: Potential gradient on the heart for the standard transvenous 
electrode configuration. The electrode voltage was again 447V. The black 
dashed line marks the approximate extent of the ventricles. 
Plate 6: Potential gradient on a section through the torso for the standard 
transvenous electrode configuration plus apical subcutaneous patch. The 
electrode voltage (215V) was just sufficient for defibrillation. 
Chapter 1 
Introduction 
This thesis is concerned with modelling the electric field produced by im-
plantable defibrillators within the human torso. Implantable defibrillators are 
devices capable of delivering high voltage defibrillation shocks through im-
planted electrodes. They are used in patients to lower the risk of sudden 
death due to ventricular fibrillation. The technology and use of implantable 
defibrillators is advancing rapidly due to the rapid development of the devices, 
electrodes and surgical techniques and because of improved understanding of 
the mechanisms and principles of defibrillation. 
A model of the electric field allows the potential effectiveness of a defibrilla-
tion shock to be assessed. In general, the effectiveness of a defibrillation shock 
depends on the torso structure, on the electrode configuration used to deliver 
the shock and on the electrical properties of the heart. The effectiveness of 
a shock from a particular electrode configuration can be assessed by firstly 
solving for the electric field. Then appropriate criteria can be applied to assess 
the suitability of the field for defibrillation and the shock strength required. 
Information can be obtained about the electric field that would be unavail-
able without the model. This can be used to optimise a system to a patient, 
to evaluate new ideas in regard to electrode configurations and to investigate 
otherwise hidden properties of the electric field. 
1 
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The model developed in this thesis used Laplace's equation as the governing 
equation for the electric field in the torso. Laplace's equation was solved 
using the boundary element method applied to a discretised torso. The major 
structures of the torso were included in the model and each was assigned an 
appropriate value of isotropic conductivity. 
The boundary element method had several advantages over a purely do-
main based method in this application. The advantages included discretisation 
using surface rather than volume elements, ease of modification of the discre-
tised torso to match patient torso geometry, attainment of accurate values of 
potentials and gradients for many configurations without extensive re-meshing 
or mesh refinement and the avoidance of iterative methods and associated 
convergence issues. 
Some approximations were made in the implementation of the model. These 
include the level of detail of some of the torso structures, the values used for 
tissue conductivity, the representation of the electrode-torso interface and the 
criteria used to determine defibrillation success. 
The model was verified using a number of techniques to ensure adequate 
performance. These included verification against analytical, experimental and 
clinical results and also against a finite element model developed specifically 
for this purpose. 
As part of the model implementation, a method was developed that signif-
icantly reduced the computation required when optimising electrode configu-
rations. Various electrode configurations were then investigated and a number 
of developments were identified for future work. 
The topics introduced above are addressed in the chapters that follow. The 
chapters are organised to deal with background material, relevant literature, 
numerical methods, implementation of the numerical methods, modelling of 
the thorax geometry, validation of the numerical methods, validation of the 
model in sheep and humans and results of investigations using the boundary 
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element model with various electrode configurations. 
Before continuing, a note regarding the discussion of methods in the thesis. 
The methods relate to a number of quite different subjects and so separate 
methods sections were retained for each. The numerical methods command 
a whole chapter while the methods of the validations and investigations are 
included as sections within the respective chapters. 
A further note is appropriate regarding the company. referred to as Telec-
tronics throughout this thesis. Telectronics was involved in this thesis as the 
industry partner in an Australian Postgraduate Research Award (Industry). 
The company details are: Telectronics Pty. Ltd., 7 Sirius Road, Lane Cove, 




This chapter presents background material relevant to the thesis on the heart 
(including the physical structure, electrical operation and mechanisms of fib-
rillation and defibrillation), the mechanism and criteria for successful defibril-
lation and how this may be included in a model, a description of implantable 
defibrillators and the defibrillation waveforms they generate and a glossary of 
terms associated with fibrillation and defibrillation. This chapter is, of neces-
sity, brief. References to more detailed discussion of these issues are given in 
the appropriate sections. 
2.2 Heart Structure and Function 
Heart structure 
The heart (Figure 2.1) is a hollow muscular organ with four chambers. The 
left and right atrium (LA and RA, respectively) are thin-walled chambers 
separated by the interatrial septum. The left and right ventricles (LV and 
RV, respectively) are thick-walled chambers separated by the interventricular 
septum and with the left wall thicker than the right. The pulmonary artery 
4 
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Figure 2.1: Heart structure 
(PA) exits from the right ventricle then branches left and right to the lungs. 
The aorta, the other major artery, exits from the left ventricle, loops over the 
heart and descends to the lower body, with branches that supply the mid- and 
upper body and the heart itself. The superior and inferior vena cava (SVC and 
IVC, respectively) are large veins from the upper and lower body that enter 
the right atrium. 
In the pulmonary circulation, blood is pumped from the right ventricle 
through the pulmonary arteries to the lungs and returns through the pul-
monary veins to the left atrium. In the systemic circulation, blood is pumped 
from the left ventricle, through the aorta to the arteries, arterioles and cap-
illaries and returns through the venules to the veins and then to the right 
atrium. The systemic circulation is a high-resistance system with relatively 
high pressures (normally 90-140 mm Hg) generated by the action of the left 
ventricle. The left ventricle is consequently very muscular with thick walls. 
The pulmonary circulation has a much lower resistance and is a relatively low 
pressure system (normally 15-28 mm Hg). The right ventricle is therefore not 
as thick as the left ventricle. 
There are four interconnecting fibrous rings that surround the openings 
between the atria and ventricles and between the ventricles and great arteries. 
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Apart from having mechanical functions, these rings electrically isolate the 
ventricular and atrial muscle. 
Heart's conducting system 
The body's natural system for stimulating heart contraction is through the 
heart's conducting system. The conducting system starts with the pacemaker 
region (the sinoatrial or SA node) located in the groove between the supe-
rior vena cava and the right atrium, which starts the heartbeat by generating 
a pacemaker potential. This potential spreads through the right atrial my-
ocardium. The atrioventricular (or AV) node receives this potential and con-
ducts it to a bundle of conductive fibres known as the AV bundle, or bundle of 
His, which passes through the atrioventricular septum and branches left and 
right down the interventricular septum. This is the only electrical connection 
between ventricles and atria in the normal heart. These branches pass under 
the endocardium and divide into a further number of branches (Purkinje fi-
bres) that finally connect to the cardiac muscle fibre. The potential travels 
through this conduction system and stimulates ventricular contraction. 
Normal electrical activity of heart muscle cells 
Normal cardiac rhythm consists of rhythmic contraction and relaxation of the 
heart muscle. The potential delivered from the pacemaker region through the 
heart's conducting system triggers depolarisation in cardiac cells in contact 
with the Purkinje fibres. The action potentials from these cells trigger the 
next cells, and so on. Previously activated cells are inhibited from immediate 
re-activation due to a refractory period after the action potential and this 
ensures activation occurs as travelling wavefronts through the myocardium 
and also that the activation, having started at the sinus node, dies out after 
the last ventricular cell has been activated. 
The cardiac muscle fibres contract and relax in response to the electrical 
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stimuli generated by individual cardiac cells. The stimuli are electric poten-
tials generated by ionic changes in the cells, made possible by the cell's ionic 
composition and semi-permeable membrane. The membrane has a differential 
permeability to ions which is dependent on the cell's state of activation. 
The most important diffusable ions are calcium, potassium and sodium. At 
rest, there is a high concentration of potassium inside and of sodium outside the 
cell, resulting from the differential permeability of the cell membrane to these 
ions. It is this, primarily, that causes a potential difference, or polarisation, 
of between -70 to -90mV found between the outside (reference) and inside of 
the resting cell. This potential is effectively an equilibrium potential resulting 
from the ionic imbalance. 
Cardiac cells are activated by a change in the resting transmembrane po-
tential. The first stage of activation is depolarisation, a rapid influx of Na+ 
followed by a slower influx of Ca 2+, resulting in the release of calcium ions 
from the sarcoplasmic reticulum (semi-fluid matrix of the muscle fibre) into 
the myofibrils (the active contractile component of the muscle fibre) which ac-
tivates the contractile process. Depolarisation occurs very quickly and results 
in the cell transmembrane potential rising to approximately 10mV. This is 
followed by the relatively slow repolarisation of the cell. This sequence lasts 
approximately 200msec and is called the action potential. 
The electrical response of the heart has the property that the magnitude 
of the response may be greater than the stimulus. In this sense, the heart's 
electrical response is nonlinear. 
Ventricular fibrillation 
Ventricular fibrillation is a life-threatening state where there is an uncoordi-
nated and ineffectual chaotic rhythm with the result that the ventricular muscle 
no longer contracts and relaxes normally. This confused, self-sustaining state 
results from disturbance to the normal activation sequence in the myocardium 
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and leads to activation wavefronts proceeding abnormally. 
The mechanism for initiation and self-sustaining of ventricular fibrillation 
is, in many cases, thought to be some form of re-entrant loop activity, a pattern 
of myocardial activation that travels a closed path and is self-propagating. A 
re-entrant loop starts with a region of unidirectional conduction and completes 
with the right timing for the myocardium to be ready for re-activation when 
the activation front returns. The loop may occur around an obstacle, such as 
the orifice of the aorta, the pulmonary artery or scar tissue. In myocardium 
that has normal conduction rates, loops would be expected to be at least 10cm 
long [3] so for more realistic small loops to form there must be regions of slow 
propagation in the loop. Slow propagation will occur if the myocardium is 
activated in the refractory period, which may happen with abnormal (such as 
ischaemically injured) myocardium. 
Functional re-entry is another mechanism for re-entry where the loop trav-
els not around an obstacle but around tissue that remains refractory [4]. This 
type of loop starts in a region where there is an abnormal distribution of re-
fractoriness. The wavefront circulates around a region that remains refractory 
due to wavelets emanating from the wavefront travelling into the region and 
colliding, their refractory wakes resulting in annihilation of the wavelets. 
Other forms of re-entrant activity have been suggested. Spiral wave ac-
tivity [5], for example, is a re-entrant activity that relies on the nonlinear 
behaviour of impulse propagation in cardiac muscle. 
The nonlinear behaviour of cardiac muscle leads to the question of whether 
ventricular fibrillation is chaotic. In this sense, chaos refers to aperiodic, irregu-
lar dynamics in deterministic systems where dynamic behaviour is determined 
by definite laws [6]. It seems that there are conflicting viewpoints to this 
question [7, 8, 9] which remains unresolved. 
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Ventricular defibrillation 
The following discussion will consider the determinants of defibrillation, in-
cluding the shock strength and distribution required for defibrillation to be 
successful, bearing in mind that the precise mechanism of defibrillation with 
electric shocks is still not fully understood and that the theory of defibrillation 
is still evolving. This section will provide the background on how success or 
failure of defibrillation may be included in the model. 
Defibrillation involves halting the fibrillation activation wavefronts. This 
is normally done by applying an electrical stimulus which depolarises all or 
most of the ventricular myocardium rendering it refractory. In the refractory 
state wavefronts can not exist so fibrillation ceases. Fibrillation can sponta-
neously re-occur if insufficient myocardium is depolarised by the stimulus or 
the electrical stimulus is too weak or too strong. 
The strength of a defibrillation shock is generally described in terms of 
potential gradient or current density. The distribution of this shock in the 
myocardium is determined by the position and structure of defibrillation elec-
trodes, the voltage waveform applied and the shape and structure of the heart 
and thorax. For successful defibrillation, the shock strength must be within 
certain limits. According to Ideker, et al., "To defibrillate, a shock must halt 
the activation fronts of fibrillation without giving rise to new activation fronts 
that re-induce fibrillation" [1]. Recently proposed mechanisms of defibrillation 
have considered the ability of the shock to initiate new activation fronts and 
to alter refractoriness [1]. 
Critical mass Early proposals for the method of defibrillation, based around 
halting activation fronts, involved halting fronts in all of the myocardium [10, 
11]. Later, it was proposed that activation fronts need only be halted in a 
"critical mass" of myocardium [12, 13], which was postulated to be around 
75% of the ventricular mass (from experiments in dogs). It was thought that 
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activation fronts in the remainder would not be self-sustaining and would die 
out. More recently, information obtained using cardiac mapping techniques 
indicates the critical mass is at least 90% of the ventricular mass [14]. 
Minimum shock strength Even though a low gradient field may halt the 
activation fronts during defibrillation it is possible for new activation fronts 
to arise leading to the resumption of fibrillation. To prevent new activation 
fronts arising, a much larger shock than the minimum to halt activation fronts 
must be applied. Minimum potential gradients of 5 to 6V/cm [15] and 4 
to 9V/cm [16] have been suggested as the minimum required if the shock is 
monophasic. A minimum current density of 35 + 5mA/cm 2 [17] has also been 
suggested, corresponding to approximately 10 — 20V/cm, depending on the 
conductivity of the myocardium. Winfree suggests a minimum current density 
of approximately 20mA/cm 2 based on empirical considerations of the heart's 
electrical responses [18]. Zhou, et al, found post-shock activation fronts were 
prevented by potential gradients greater than 5V/cm [14]. 
Shocks of this magnitude raise all the myocardium above the upper limit of 
vulnerability (the maximum stimulus beyond which fibrillation is not evoked) 
so that the myocardium remains unexcited after the shock thereby inhibiting 
the development of new activation fronts and preventing the re-establishment 
of fibrillation. 
There is no sharp cut-off in the relationship between shock strength and 
defibrillation success, rather there is a dose-response type curve, as illustrated 
in Figure 2.2. Strong shocks have a higher chance of success than weak shocks. 
A very strong shock will virtually guarantee defibrillation while a very weak 
shock will usually fail. When discussing defibrillation, it is usual to refer to a 
ventricular defibrillation threshold (DFT) which is usually defined as the shock 
strength giving a 50% (or sometimes 80 or 90%) probability of success. 
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Shock strength 
Figure 2.2: The probability curve for defibrillation (from Ideker et al. [1]) 
Maximum shock strength As we have seen, it is necessary to apply a 
relatively large shock to virtually all of the myocardium for successful defibril-
lation. It is important, though, not to apply an excessively large shock as this 
may cause the resumption of fibrillation and temporary or permanent damage 
to the myocardium. Potential gradients above 60V/cm temporarily disable 
pacing and conduction [19] while a potential gradient of 80V/cm is sufficient 
to induce permanent damage to myocardial cell cultures [20]. 
Babbs et al [21] investigated the ability of transchest defibrillator shocks 
to produce defibrillation, myocardial damage and death in 101 dogs. Damage 
was assessed by physical examination of the myocardium. They found that 
damage occurred at 5 times the current and 20 times the energy required for 
defibrillation, and death occurred at 22 times the current and 320 times the 
energy for defibrillation. Also, the risk of detectable damage was 2 to 4% for 
90% successful shocks and 5 to 10% for 99% successful shocks. 
Monophasic versus biphasic waveforms Waveform shape also influences 
defibrillator performance. As biphasic waveforms have been found to be more 
effective than monophasic, it has been suggested that different mechanisms of 
threshold reduction may operate [22]. Blanchard and Ideker discuss possible 
mechanisms that increase biphasic over monophasic efficacy, including less 
conduction block in regions of high potential gradient, lower potential gradient 
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required for defibrillation in low gradient regions, less ability of some biphasic 
shocks to stimulate the myocardium and the effect of the second phase on 
reversing or returning the transmembrane potential to its original level [23]. 
There has also been evidence against the extension of the refractory period 
with biphasic shocks [24]. 
Zhou, et al, found potential gradients of approximately 5V/cm for monopha-
sic waveforms and 3V/cm for biphasic gave an 80% chance of successful defib-
rillation [14]. They found no clear reason for the greater efficacy of the biphasic 
waveform. 
Spatial variation in minimum shock strength that induces fibrilla-
tion There is spatial variation in the shock strength needed for fibrillation. 
Horowitz, et al., found the shock strength needed was at least 50% higher in 
the left ventricle than in the right ventricle [25] while Burgess, et al., found 
the shock strength needed to be higher in the anterior than the posterior wall 
of the left ventricle [26]. 
Variation in required shock strength between patients Hillsley, et al., 
discuss high defibrillation thresholds in some patients [27]. They say that 
"A high defibrillation threshold may occur because: (1) a shock 
creates a subthreshold potential gradient in the low gradient areas; 
(2) a patient has a higher minimum potential gradient threshold 
than other patients; or (3) a shock leads to refibrillation in the high 
gradient areas." 
As always, the natural variation within humans means it is difficult to interpret 
the clinical data. 
There is still considerable debate about the actual mechanisms of defibrilla- 
tion and the reasons why there is a dose-response curve, but while the exact 
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mechanisms of defibrillation are still to some degree uncertain, a workable cri-
teria for defibrillation is that the defibrillation threshold (DFT) is the shock 
strength giving a minimum potential gradient everywhere in the myocardium 
of approximately 5V/cm (for monophasic waveforms) and a maximum not ex-
ceeding approximately 80V/cm. This is the criteria that will be used in the 
model that is the subject of this thesis. 
It has also been shown that defibrillation response is partly dependent on 
electrode polarity [28], though the reasons for the dependance are not fully 
explained. The above defibrillation criteria is therefore a simplification of the 
true mechanism of defibrillation as it does not take into account the depen-
dance on polarity. While it is desirable to avoid such a simplification, the 
rigorous treatment of polarity dependance is beyond the scope of this thesis. 
2.3 Early History of Defibrillation 
In 1899 Prevost and Battelli found that ventricular fibrillation was induced 
by applying alternating current (AC) directly onto the heart of animals [29]. 
They also found that stronger intensity AC applications and capacitor dis-
charges could be used to defibrillate the heart. Their AC results were con-
firmed in 1930 by Langworthy and Kouwenhoven, who also suggested that 
the defibrillating shock needed to affect the entire heart to be successful, and 
showed a ventricular fibrillation duration of two minutes or more generally 
led to death [30, 31, 32]. Prevost and Battelli's capacitor discharge results 
were confirmed in the 1940's by Gurvich and Yuniev [33]. The first success-
ful human defibrillation was in 1947, using a 110V AC device with the heart 
exposed [34]. This technique required immediate thoracotomy. Zoll, in 1955, 
performed the first transthoracic defibrillation, using 240-270V AC and 7.5cm 
diameter copper electrodes [35]. At this stage, AC, rather than DC, waveforms 
were established as the preferred method of defibrillation. 
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Lown, et al, in 1962, found that direct current (DC) shocks with a damped 
sinusoidal waveform reduce the chance of post-shock arrhythmias and elec-
trocardiographic repolarisation changes (in dogs) [36]. This work led to the 
recognition of the superiority of damped sinusoidal DC waveforms over AC 
waveforms. DC defibrillators were subsequently developed that were small 
and could be battery powered and therefore portable. These defibrillators still 
needed a relatively large inductor to generate the required waveform. 
During the 1960's and early 1970's, truncated exponential waveforms were 
recognised as effective waveforms that eliminated the need for an inductor [37, 
38, 39, 40]. This advance was one of the factors that enabled the development 
of an automatic defibrillator that could be implanted in humans. 
Further and more complete discussion may be found in articles such as 
those by Troup [41] and Mitrani et al [42]. The discussion of implantable 
defibrillators is continued in the following section. 
2.4 Implantable Defibrillators 
The implantable defibrillator was developed independently by the groups of 
Mirowski [43] and Schuder [44]. These early proponents of implantable defibril-
lators encountered spirited discussion with their peers, including, for example, 
a disparaging editorial by Lown and Axelrod [45]. They implied implantable 
defibrillators were impractical because of potential electrical injury to the heart 
and difficulty in determining satisfactory electrode positions because of "the 
complex geometry and electrophysiologic properties of a particular heart which 
cannot be readily modelled". They even went on to say "... the implantable 
defibrillator system represents an imperfect solution in search of a plausible and 
practical application" and likened an implantable defibrillator to an electronic 
gadget that "was developed only because it was possible". This discourage-
ment, though, most likely reflects the magnitude of the difficulties involved 
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with developing the implantable defibrillator, and the scepticism surrounding 
its feasibility. 
In spite of the discouragement, Mirowski's group continued with the devel-
opment of the implantable defibrillator. They overcame problems relating to 
miniaturisation of the device, determination of effective energy levels, selection 
of an appropriate waveform and electrode configuration, development of spe-
cial power sources and creation of a reliable sensing system [46]. Early tests of 
the implanted system in dogs were successful [46] and were followed by trials 
in humans [47], leading to approval by the USA Food and Drug Administra-
tion in 1985 and manufacture by Cardiac Pacemakers, Inc. Since then, many 
types from various manufacturers have been approved and the implantable 
defibrillator is now in widespread use, with good acceptance by the medical 
community. 
A typical implantable defibrillator system (Figure 2.3) consists of a pulse 
generator connected to implanted electrodes. The pulse generator contains ca-
pacitors which are charged from batteries then discharged between implanted 
electrodes. Pulse generators have a titanium shell and generally use two 
lithium silver vanadium oxide batteries to supply a total of 6.4V to the defib-
rillator circuitry. The circuitry enables the defibrillator to be programmed to 
sense the heart's electrical or physical activity and to deliver the appropriate 
response, and incorporates voltage multiplication circuitry to attain high volt-
age output for defibrillation. Defibrillators weigh from about 240g for older 
models to just over half that for new models. Defibrillation output is up to 
40J and 750V. 
Implanted electrodes were originally titanium mesh patches that were sewn 
to the epicardium. Although efficacy was good, implantation required thora-
cotomy with associated complications and mortality. Transvenous lead sys-
tems were introduced in 1993 [48, 49] and were associated with less serious 
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Figure 2.3: Example of a common implantable defibrillator system, with a pulse 
generator, transvenous electrodes in the right ventricle (RV) and superior vena 
cava (SVC) and a subcutaneous (SQ) patch electrode 
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are implanted through the venous system and consist of small diameter leads 
incorporating sensing, pacing and defibrillating electrodes. Typically, one de-
fibrillator electrode is positioned in the right ventricle combined with at least 
one other electrode. Possibilities include transvenous electrodes in the right 
atrium, coronary sinus or superior vena cava, subcutaneous patches or the 
pulse generator casing. Sometimes combinations are used without a right ven-
tricular electrode. 
2.5 Defibrillator Voltage Waveforms 
Many defibrillator waveforms (Figure 2.4) have been tested with different de-
grees of success. The descending ramp (a) has been found to have a high 
likelihood of failure, probably because of the descending tail [50], while square 
waves (b) are more effective [51]. AC waveforms (c) are successful[34, 52], but 
are disadvantaged by their need for large transformers and gated output [53] 
and their tendency to induce atrial fibrillation [36]. Damped sinusoidal wave-
forms (d), though, are effective [54, 55, 36] and are used in most commercially 
available external defibrillators [56]. 
The capacitor discharge (e) is a simple waveform which, unfortunately, 
produces unpredictable outcomes since the long tail can re-induce fibrilla-
tion [50], and which requires about twice the energy of a damped sinusoidal 
waveform [54]. Truncated exponential waveforms, though, are effective and 
are used extensively. Three types of truncated exponential waveforms used are 
monophasic, biphasic and sequential (f, g and h). The efficacy of monopha-
sic waveforms is comparable to that of damped sinusoidal waveforms [57]. 
Recently, though, the superior efficacy of the biphasic waveform has been 
shown [58, 59, 60, 61, 62, 63] and it is now commonly used in implantable 
defibrillators. There has been no conclusive evidence that sequential wave-
forms are superior to monophasic [64, 65]. 
— 
e. Exponential 	I. Monophasic g. Biphasic 	h. Sequential 
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a. Descending ramp 	b. Rectangular 	c. Sinusoidal d. Damped sinusoidal 
Figure 2.4: Examples of potential defibrillator waveforms, plotted as voltage 
versus time. Truncated exponential, biphasic and sequential waveforms are 
commonly used with implantable defibrillators. 
2.6 Glossary 
Ventricular fibrillation threshold 
The ventricular fibrillation threshold (VFT) is the minimum stimulus that will 
evoke fibrillation and is usually specified in terms of voltage or energy. 
Vulnerable period 
The vulnerable period is the period of ventricular activation during which 
fibrillation is most easily induced. This is the repolarisation interval of normal 
rhythm. 
Defibrillation threshold 
The ventricular defibrillation threshold (DFT) is a measure of the shock strength 
required for successful defibrillation. In practice, this is usually the shock giv-
ing a 50% probability of success. 
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This review will focus on modelling of the electric field in the torso, particu-
larly numerical models of implantable defibrillators, but also the related issues 
of the electrical properties of tissues, the interface between electrodes and the 
torso, the construction of torso geometry for models, the numerical solution 
strategy employed in models, model validation and the optimisation of elec-
trode configurations. The review will also include discussion of defibrillation 
threshold and resistance values that have been measured in humans from use 
of implantable defibrillators with numerous electrode configurations. 
3.2 Modelling 
The modelling of the electric field in the torso considered in the thesis fits into 
the category of forward models of electrocardiology. In forward models, sources 
of potential in the torso are known and the electric field is calculated, given the 
structure of the torso. This is distinct from inverse models, where knowledge 
of the surface electric field is used to find unknown source potentials. We will 
consider various models that have been developed to date and, in particular, 
20 
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those models that predict the electric field of defibrillators. 
Torso models 
Early models of the electric field in the torso include both physical and ana-
lytic models. Physical models include those of Burger and Milaan [66], Nelson 
et al [67] and Rush [68]. These models used resistor networks, electrolytic 
solutions, tanks, bladders, electrodes, and so on, in their construction making 
them time-consuming to create and modify. Though often ingenious in con-
cept, they also often had limited application. Analytic models include those 
of Rush and Nelson [69] and of Rudy and Plonsey [70]. These were used to 
arrive at various theoretical predictions, but, were limited by the degree of 
complexity of torso structure that could be represented. 
Numerical models became feasible with the advent of the modern computer 
in the 1960's and 1970's. In a numerical model, the electric field can be found 
using potential theory by solving Laplace's equation [71], which applies in this 
case because torso tissue is almost purely resistive at low frequencies. Initially, 
numerical torso models were often limited to two-dimensions to match their 
size and complexity to the early computers. Increases in computer capacity 
and processing power subsequently allowed realistic three-dimensional models 
to be developed. Some of the limitations of two-dimensional models were that 
representation of three-dimensional geometry was often unsatisfactory, values 
for electrode resistance, defibrillation voltage and energy was often in gross 
error, and electrode configurations were often unrealistic. Sepulveda et al [17], 
for example, developed a two-dimensional finite element model of the canine 
heart and torso and used it to compare a number of implantable defibrillator 
electrode configurations. The model included muscle, lung, myocardium and 
blood with isotropic conductivities. Although the model was useful to some 
degree, some of their findings, such as the shunting of current through the 
blood when using a two-electrode catheter, were exaggerated because the field 
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was constrained to be two-dimensional and because it was only possible to 
space the electrodes close together. 
The remainder of the discussion will be of three-dimensional models. Nu-
merical torso models developed in the 1960's include those of Gelernter and 
Swihart [72] and Gelernter et al [73], who calculated torso potentials using in-
tegral equations for a hemispherical dipole layer within a torso. Another was 
developed by Barnard et al [74], who used a unit dipole source and realistically 
shaped blood masses. Selvester et al [75] and Cuffin and Geselowitz [76] used 
20-dipole heart models within a torso that included lungs. They found that 
the body surface potentials were not changed much by inclusion of the lungs. 
Horacek [77] developed a model in the early 1970's which was modified 
by Gulrajani and Mailloux [78] a decade later. They used an integral equa-
tion approach to study the effects of inhomogeneities on the electrocardio-
gram, vectorcardiogram and the body surface potential map. Their model in-
cluded the torso surface, lungs and the heart's blood masses. The anisotropic-
conductivity skeletal muscle layer was taken into account by the boundary-
extension method, with the body surface moved outward, as suggested by 
Rush et al [79]. In the mid 1980's, Stanley et al also used Rush's boundary-
extension method [80], and then discussed its accuracy [81], concluding that it 
could be utilised only for regions of constant anisotropy and was only accurate 
for flat or slowly changing surfaces. 
Also in the mid 1980's, Walker and Kilpatrick [82, 83] developed models 
for the forward and inverse problem of electrocardiology. These were based 
on a finite difference method using a resistive network and included the heart, 
lungs, spine and sternum. The models defined the torso geometry using a mesh 
constructed from digitised CT scans. Each mesh contained approximately 
20, 000 nodes, arranged with a variable spacing to attain an increased density 
near the heart. Although the node spacing was irregular, the sides of each 
element were constrained to be parallel, to satisfy the requirements of the 
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finite difference method. In a later study of acute inferior myocardial infarction 
Kilpatrick et al [84] recorded body surface potentials of 219 patients and then 
used the inverse model to calculate epicardial potential maps. They found that 
31% of the patients had two characteristic dipole patterns on their epicardial 
maps and that these patterns were associated with a mortality rate of 35% 
compared with 5% in the remaining patients. 
In the late 1980's and early 1990's, Stanley and Pilkington [85, 86] presented 
a numerical method for electrocardiographic potential calculations which com-
bined the boundary and finite element methods. They were the first to apply 
the combined method to an electrocardiographic calculation. The advantage 
of the method was in finding potentials in a volume that had both isotropic 
and anisotropic regions. The advantages of the boundary and finite element 
methods could be exploited in the respective regions. 
This decade, Johnston and Kilpatrick [87, 88] developed a boundary ele-
ment model of the forward problem of electrocardiology. The model mapped 
the potential from the epicardial and endocardial surfaces of the heart onto 
the body surface. The model used approximately 5000 linear quadrilateral 
elements and included the heart, lungs, spine, sternum and general body tis-
sue. The heart was subdivided into regions of heart muscle and blood, with 
the blood providing an electrical pathway from the endocardium to the body 
surface. The electric field at the body surface was found to be influenced by 
this previously omitted electrical pathway. 
• Recently, Pullan et al [89] developed a coupled boundary and finite element 
torso model for use in the forward (and inverse) problems of electrocardiology. 
This model used higher order elements, which made creating the mesh difficult 
but resulted in good definition of the surfaces with few elements. Meshing 
the epicardium, lungs, skeletal muscle, fat and outer torso required only 658 
elements. The coupling of boundary and finite elements allowed finite elements 
to be used in regions of anisotropic conductivity. 
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Defibrillation models 
Defibrillation models have been developed for both transthoracic and im-
plantable defibrillators. Most of the relevent literature is work that has been 
done concurrently with the work described in this thesis and has been reported 
only in conference proceedings. 
A volume conductor model of the torso was developed by Claydon et al [90] 
for the study of defibrillation fields in the late 1980's. The model included 
skeletal muscle surrounding a body compartment containing the lungs and 
heart. The model represented skeletal muscle by the boundary-extension ap-
proximation of Rush (discussed above), allowing this anisotropic region to be 
represented as isotropic. The simplified heart was modelled as isotropic and 
without cavities. They used boundary integral equations to predict epicardial 
potentials from a transthoracic stimulus and compared this to measured values 
in experiments on three dogs. They found average RMS error and correlation 
coefficient of 47.3% and 0.901, respectively, for a homogeneous torso with or 
without lungs (!), and 42.1% and 0.914 with the skeletal muscle layer. The 
relatively good correlations were surprising considering their model had very 
simple geometry and only a relatively small number of nodes to represent the 
body structure. It is also surprising that the inclusion of the lungs had no 
discernible effect, especially considering the low conductivity of the lungs. 
There have been a number of recent conference papers relating to models for 
transthoracic defibrillation. Karlon et al [91] developed a finite element model 
of the canine torso for use in the study of transthoracic electrical defibrillation. 
The model was constructed from 21 cross-sectional CT scans, each separated 
by 0.82cm. Eight distinct tissues were incorporated, including anisotropic 
properties of skeletal muscle. The model contained approximately 9, 000 nodes 
and 45, 000 linear tetrahedral elements. Results obtained using the model were 
found to compare well with published in vivo experimental data. 
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A transthoracic defibrillation model was developed by Camacho et al [92, 
93]. The torso was of an average adult male torso constructed from 22 serial 
cross-sectional CT scans spaced 1cm apart obtained from an atlas of com-
puterised tomography [94]. The model included 130,000 linear tetrahedral 
finite elements defined by 23,000 nodes with isotropic conductivities for car-
diac muscle, liver, lung, bone, blood, skin, fat, mediastinum and anisotropic 
conductivity for skeletal muscle. In one study [92], they compared 4 defibril-
lator paddle pairings and 2 paddle sizes. They used a critical mass criterion 
that 75% of the heart needed to be exposed to a threshold current density of 
at least 30mA/cm 2 for defibrillation to be successful. They found that none 
of the myocardium was exposed to current densities greater than four times 
the threshold, noting that myocardial damage has been found with current 
densities of ten times the threshold or more. The fraction of total current 
flowing through the myocardium was 20 — 45%, which was within the range 
estimated by others, and impedance values were similar to reported human 
transthoracic impedance. They concluded that the agreement between their 
finite element model results and physical measurements of others suggested 
that finite element modelling provided a reasonable description of the con-
duction process during defibrillation. In a further study [93], they considered 
the effects of epicardial patch electrodes on transthoracic defibrillation. They 
found that the presence of conformal patches on the epicardium increased the 
current necessary for defibrillation by up to 33%. 
A boundary element model of transthoracic defibrillation was developed by 
deJong et al [95]. The torso was constructed from 90 transverse MRI images of 
the human torso, using 1008 triangular elements for the torso surface and 480 
for the epicardium. Although not included in this model, they also constructed 
surfaces representing the fat, skeletal muscle, lungs, spine and endocardium. 
From knowledge of the defibrillation electrode position and voltage, they cal-
culated the applied intrathoracic current and epicardial potentials, and from 
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these the epicardial current distributions and amount of transcardiac current, 
which was within the range of 21 — 31% of the total electrode current. 
Patterson and Wang [96] developed a finite difference model for external 
defibrillation. The torso geometry was constructed from 40 MRI scans at 
lcm spacings from an adult male and contained 216, 000 elements. Values 
of resistivity used in the model were measured in their laboratory and had 
values of 15011cm for blood, 40011cm for myocardium, 40011cm for skeletal 
muscle, 140011cm for lung and 200011cm for fat and bone. They compared the 
performance of different electrode sizes and positions finding that from 16% to 
23% of the total current flowed through the heart. 
Cansell et al [97] developed a resistor network finite difference model for 
finding the electric field from implantable defibrillators. They used the model 
to find the optimal position of electrodes in a right-ventricular to multiple 
subcutaneous patch configuration and compared this to results found experi-
mentally on pigs and dogs. It seems they found good agreement between the 
model and pig experiments, though their discussion was not particularly clear 
on this point. However, they did find that their experiments on pigs were 
more valuable than those on dogs because the anatomy and size of pigs more 
closely matched humans. Electrode positions in pigs had a significant effect 
on defibrillation thresholds, whereas in dogs, electrode positions were found to 
have only a small effect. 
There have been a number of recent conference papers relating to models of 
implantable defibrillators. A FE model of the human torso was used by Kinst et 
al [2] to find the electric field from epicardial, endocardial and subcutaneous 
electrodes. This appears to be basically the same model used by Camacho 
et al [92, 93] but used with internal rather than external electrodes. They 
found values of inter-electrode impedance and defibrillation threshold voltage 
and current to be comparable to reported clinical values. Their calculated 
impedance and voltage, and energy derived from these assuming a 150/2F 
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Pairing Z Vth Energy 
(n) (V) (J) 
epi-conform 36 253 4.44 
epi-32 49 318 6.49 
epi-16 72 430 10.1 
RV-10 to SQ 71 733 29.5 
RV-5 ro SQ 76 689 25.1 
RV-5 to SVC-5 46 537 18.9 
Table 3.1: Internal defibrillation simulation results (from Kinst et al. PD. 
Epicardial patch pairs were: 54cm 2 conformal (epi-conform), 32cm 2 (epi-32) 
and16cm 2 (epi-16). RV-10, RV-5 and SVC-5 designate location and length (in 
cm) of endocardial electrodes and SQ was a 25cm 2 subcutaneous patch. Energy 
was derived assuming 150pF capacitor and 7ms pulse. 
capacitor and 7ms pulse, is shown in Table 3.2. 
Some finite element models have been based on a regular grid approach. 
One such model was developed by Seneta and Holley [98] for implantable de-
fibrillators. The model was based on a regular orthogonal mesh using linear 
tetrahedral elements combined to form cubic structures. In concept, the model 
was similar to to a finite difference model, with similarly short solution times 
due to the regular mesh. The main disadvantage with the model is that the 
enforced regularity of the mesh means it is impossible to have local concentra-
tions of nodes if required for physical or computational accuracy. This may 
result in difficulties when modelling fine anatomical structures, small electrodes 
or regions of large potential gradient. Another model was developed by Gao 
et al [99], who dealt with the resolution difficulties of regular grids by using a 
very fine grid combined with a massively parallel computer to do the compu-
tations. Using over 4 million nodes they could arrive at a solution in less than 
10 minutes for a three dimensional anisotropic medium. 
In 1995, Jorgenson et al [100] described a finite element model for transtho-
racic and transvenous defibrillation. Their model contained approximately 
400, 000 nodes and hexahedral elements arranged as a uniform mesh. They 
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found that commercial packages using banded matrix solvers could not handle 
their large problems (running on an IBM RS/6000 with 128 Mbytes of mem-
ory) so they successfully implemented their own solver using a Gauss-Seidel 
iterative scheme with over-relaxation. The torso mesh used was constructed 
from 56 transverse CT scans at 6mm intervals of an adult male human. They 
used a fast scanner and radiopaque contrast material to enhance the CT images 
and allow detailed anatomy of the heart to be extracted. They averaged blocks 
of 4x4 pixels on each scan and the resulting pixels were used as nodes in the 
model. Tissue was classified as either skin, fat, skeletal muscle, blood, bone, 
lung internal air, myocardium, gut or liver using an image segmentation algo-
rithm followed by manual completion of unresolved or incorrect classifications. 
The myocardial tissue was represented by 6611 elements. They tested the 
model's sensitivity to tissue resistivity values and electrode size and position. 
To validate the model results, they predicted thoracic voltages in 3 experimen-
tal animals, finding squared correlation coefficients between experimental and 
calculated voltages from 0.89 to 0.98, indicating excellent agreement. 
It is possible to automatically optimise electrode position by repetitively 
solving the model using appropriate optimisation algorithms to suggest mod-
ifications to the electrode configurations. Seneta and Holley [101] developed 
a program to automatically optimise electrodes for a number of geometric 
and performance criteria when used with their regular grid finite element 
model [98]. The optimisation algorithm used was "very fast simulated re-
annealing" [102] and the performance criteria included bounds on electrode 
positions and goals such as maximising the magnitude or uniformity of the 
electric field. A cost function determined how closely the results from the 
finite element model matched the user-defined goal and the optimisation algo-
rithm found the global minimum over the range of variation of the parameters. 
Hutchinson and Kwong [103] developed an optimisation algorithm for a finite 
element transcardiac defibrillation model. Their method was to optimise for 
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electrode position and voltage using current density in the myocardium as the 
performance Criteria and the quasi-Newton optimisation algorithm [104]. 
Torso construction 
Min et al [105] developed a detailed torso geometry suitable for use in a finite 
element model. They used 49 CT slices with 6mm separation covering the 
torso from neck to diaphragm. They first generated two-dimensional contours 
to classify the boundaries of 27 tissues or organs of interest. They generated 
three-dimensional solids from these contours using commercial solid modelling 
software (IDEAS by SDRC, Milford, OH) or a Delauney mesh generator [106, 
107] after defining an electrode geometry. Their method of torso construction 
could realistically represent anatomical and electrode geometry which, they 
suggest, may be difficult to do using simpler techniques (brick elements, for 
example). 
The high order mesh developed by Pullan et al [89] was developed from an 
array of points on MRI slices at 5mm separation defining the boundaries of 
the lungs, heart, skeletal muscle, fat and outer torso. One dimensional cubic 
hermite elements were fitted to the points using a finite element procedure 
that minimised the root mean square (RMS) error of the orthogonal distance 
of the data points to the mesh. The two-dimensional boundaries were then 
connected vertically to form three-dimensional surfaces. They then used the 
finite element fitting procedure to minimise the RMS error between these sur-
face elements and the original data points. Three-dimensional finite elements 
were created manually in the skeletal muscle and fat layers. 
Odesanya et al [108] describe a method of constructing biological surface 
models from cross-sections and demonstrated their method by reconstructing 
the bone of a human hand. Their method was to first fit piecewise cubic B-
splines through representative data points on the cross-sections, then create 
a mesh of quadrilateral patches over adjacent cross-sections using bicubic B- 
CHAPTER 3. LITERATURE REVIEW 	 30 
spline surfaces, with second derivative continuity between the patches. They 
suggested that renderings of models indicated the method produced qualita-
tively acceptable results. 
Image processing techniques can be used to extract boundary regions from 
cross-sectional scans. Although one of the main advantages in doing this is 
to automate the process of generating the torso geometry for a model, full 
automation is difficult to achieve. For example, Nadeem et al [109] presented 
an image processing technique and a boundary approximation algorithm for 
use in model construction. Although the boundaries for the heart, lungs and 
skeletal muscle were successfully extracted from a cross-sectional CT scan of 
a human, it was still necessary for human interpretation of the results and 
building of the final mesh. 
Tissue properties 
Human tissue has resistive and reactive components of impedance and there-
fore, in general, tissue impedance is frequency dependent [110]. However, the 
characteristic frequency of implantable defibrillator waveforms is about 100Hz 
and at this frequency the reactive components reduce to near zero [111, 112] 
and so the tissue may be considered to be purely resistive. 
Many people have measured tissue resistance. The values found depend on 
the method and specimens used and consequently some of the reported values 
are spread over a wide range. Some reported values are listed in Table 3.2. 
Though the electrical resistance of muscle is anisotropic, some workers have 
measured just an average value of resistance for this tissue. 
Swerdlow et al [116] looked at the effects of voltage and respiration on 
impedance in nonthoracotomy defibrillation pathways. They used shocks rang-
ing from 65 to 745V and found impedance varied inversely with voltage (by 
up to 17% for transvenous-SQ, 8% for transvenous and 3% for epicardial) 
while respiration increased impedance only for transvenous-SQ. The voltage 
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Author Resistivity (Skm.) 
Heart Muscle Lung Blood Fat Bone Abdomen 
Geddes and 400 300(1) 1500 150 2500 
Baker [113] 1600(0 
Barber and 410(1) 530 1500 150 2430 1660 
Browna 	[114] 750(t) 727-2364b 
Rush [79] 400 2100 160 2100 oo 
Pluta [115] 147(1) 555 140 2000 oo 285 
250(0 
a Mostly averaged results from many authors 
bRange from expiration to inspiration 
Table 3.2: Reported values of conductivity (T is longitudinal, 't' is transverse). 
dependence of impedance was found to be greatest in the lungs. 
Wharton et al [117] investigated the effect of shock strength on impedance 
in dogs using epicardial electrodes and shock strengths ranging from 1 to 
1000V. They found that at low voltage (less than 25V) impedance was higher 
than at high voltage by up to a factor of four. Although some of this effect may 
have been from electrode polarisation, they suggested that the capacitance of 
the myocardium changed as a function of the delivered potential. Nevertheless, 
they concluded that impedance appears to be primarily resistive in the range 
of potentials necessary for defibrillation. 
Electrode -torso interface 
The interface of the implanted electrode and the torso is usually modelled as 
a perfect interface with zero impedance. In reality, however, the impedance 
is not zero, though it is usually relatively small. Brigitte and Gisela [118] 
reported on energy loss due to polarisation for several electrode materials. 
Schimpf et al examined the impedance of an electrode-electrolyte interface for 
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transvenous electrodes [119], finding a polarisation impedance of between 2% 
and 5% of the overall impedance for typical tranvenous pathways in humans 
and pigs. 
Panescu et al [120] developed a nonlinear finite element model of the 
electrode-electrolyte-skin system. The model took into account the nonlin-
ear behaviour of the skin with respect to the amplitude of the voltage. 
Model validation 
Validation of torso models is an interesting topic that presents many practi-
cal difficulties. The following discussion illustrates examples of torso model 
validation procedures and results from a number of workers. 
Barr and Spach [121] calculated epicardial potential distributions from mea-
sured body surface potentials for twelve dogs. Epicardial electrodes were im-
planted, with insulated wires extending subcutaneously to the lower abdomen, 
and the body surface potentials were allowed to return to normal (taking about 
2 weeks). They then recorded the potential distributions on the 75 epicardial 
and 150 body surface electrodes, and calculated forward and inverse transfer 
coefficients between the epicardium and body surface, assuming the torso was 
a homogeneous volume conductor. They found that between the inverse com-
puted and measured epicardial distributions, the relative error was high, often 
0.7 or more, while the correlation coefficients were in the range 0.6-0.8. They 
concluded that the main physical features of epicardial potential distributions 
could be found from body surface measurements. 
Messinger-Rapport and Rudy [122] placed a beating dog's heart in an epi-
cardial cage and placed this in the correct anatomical position in a human-torso 
tank. They compared epicardial potentials measured on the epicardial cage to 
those calculated with an inverse model. Through the cardiac cycle, they found 
that the relative error was a minimum of 0.35 and a maximum of 1.0, with an 
average of 0.51. They also found that positions and shapes of features of the 
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potential map were recovered with good accuracy, with an error in position of 
lcm being typical, while the amplitudes of these features were reduced slightly. 
Derfus et al modelled a multi-electrode intracavity probe in the left ventri-
cle and used the model to calculated the left ventricle intracavitary potentials 
from measured subendocardial potentials during pacing from a number of al-
ternative sites [123]. Their model used the Boundary Element method to solve 
Laplace's equation. They compared the calculated potentials to potentials 
measured on the intracavity probe. They found that the accuracy of their 
prediction depended on the pacing site, the best being from apical pacing sites 
with a correlation coefficient of 0.989 ± 0.002, indicating excellent agreement 
for this type of study. However, from other pacing sites the correlation coef-
ficient was lower (averaging 0.873 ± 0.092) due to errors in measuring probe 
position and LV cavity geometry. 
Shahidi et al [124], recorded epicardial and body surface potentials in a 
human to validate their model of the inverse problem of electrocardiology. The 
model was a FE torso model which they used to compute transfer matrices 
relating epicardial to body surface potentials for a patient, using different mesh 
resolutions and conductivity inhomogeneities. The epicardial potentials were 
measured using a 63 electrode heart sock during open chest surgery, while 
the body surface potentials were measured, also with 63 electrodes, prior to 
surgery. They found the measured epicardial potential distributions could not 
be adequately recovered from the body surface potential distributions using 
the inverse model, finding relative errors > 1 and correlation coefficients < 0.4. 
However, they were able to locate the ventricular pre-excitation site. They 
suggested that the main experimental errors occurred due to the chest being 
open and the heart exposed to air when the epicardial potentials were recorded, 
and due to difficulties in determining the epicardial lead locations. 
Kilpatrick and Walker [125] validated their inverse model in humans by 
predicting the coronary artery that had been involved in episodes of acute 
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myocardial infarction. They used a body surface mapping jacket with 51 
electrodes and a resistor network model of the human torso. They found that 
the epicardial map correctly predicted the coronary artery involved in 40 out 
of 55 patients, and partially predicted the artery involved in 8 of the remaining 
patients. They concluded that the model did predict sensible epicardial maps 
from body surface potentials. 
3.3 Clinical Results using Implantable Defib-
rillators 
Current practice using implantable defibrillators [126, 127, 128, 42] is tending 
towards simple endocardial configurations whenever possible and away from 
surgically invasive epicardial systems requiring thoracotomy. This has resulted 
in implantation being safer and cheaper in most instances and implantation is 
now sometimes as straightforward as with a pacemaker, though there are still 
a significant proportion of patients who, because of their high defibrillation 
thresholds, require one of the more complicated electrode systems and must 
undergo more extensive surgical procedures[129]. For all patients, use of sys-
tems with lower energy requirements is better physiologically and allows use 
of smaller defibrillator units. 
Reported configurations and performance from sixteen investigations are 
summarised in Table 3.3. This table lists the object of each investigation, the 
electrodes, waveform and number of patients used, the anode-cathode resis-



















Investigation Defibrillation pathway Waveform 










01a Waveform phase RA -■epi mono/65 27 37.2 ± 5.5 417 ± 66 < .0001 10.9 ± 3.3 < .0001 [130] 
Olb RA -■epi bi/53 27 38.0 ± 6.6 353 ± 67 7.6 ± 2.9 
02a SQ patch position RV -SVCI-S0_,,pectora i 9 16.9 ± 5.4 <.04 [131] 
02b RV --rSVC+SQsubscapular 9 11.2 ± 3.9 
03a SQ patch position RV -.SVC/CSA-SQmid-asillary simult 30 17.4 ± 1.3 < .005 [129] 
03b RV -*SVC/CS+SCLubscaputar simult 30 14.2 ± 1.2 
03c Simultaneous vs RV -*SVC/CS -1-SOumid-asillary seq 30 20.2 ± 1.5 < .002 
03d sequential shocks RV -■ SVC/CS -FSC3ub3cap.tar seq 30 18.5 ± 1.1 
04a Additional CS RV+ -*AC - bi/65 10 451 ± 104 .37 12.9 ± 5.7(s) .39 [132] 
04b electrode (RV-FCS)+ -AC- bi/65 10 408± 115 10.8± 5.4(s) 
05a Waveform tilt RV+ ..AC-  bi/65 15 347 ± 125 .67 7.6 ± 5.0 .17 [133] 
05b RV+ -*AC- bi/50 15 359 ± 124 6.1 ± 4.0 
06a Electrode polarity proximal+ -*distal- mono 16 50 ± 6 16.4 ± 7.3 < .01 [28] 
06b proximal- -.distal+ mono 16 51 ± 5 11.7± 5.7 
07a Trans vs Epi epicardial 434 13.8 < .001 [134] 
07b transvenous 317 9.2 
08a SQ patch trartsvenous -I- SQ 21 9 ± 4 <.05 [135] 
08b trartsvenous 21 12 ± 4 
09a Mono/biphasic transvenous and/or SQ bi 42 9 ± 4 < .001 [135] 
09b transvenous and/or SQ mono 21 - 	14 ± 5 
10 Trans. efficacy transvenous 68 11.1 ± 4.6 [136] 
11 Trans. efficacy transvenous 25 14.0± 4.4 [137] 
12 Epi. efficacy epicardial (2 or 3 patches) 238 8.6 ± 5.3 [138] 
13a SQ patch RV- --oRA+SQ ■ ef t-inf ra-clavicular bi 12-14 473 ± 97 14.3 ± 5.3 [139] 
13b position RV - -.RA+SQi nf ra-axillary bi 12-14 405 ± 80 < .01 10.2 ± 3.8 < .02 
13c RV- -41.A÷SQopicat-cardiac bi 12-14 479 ± 84 14.4 ± 4.8 
14a Simultaneous vs RV -.SVC/CS+SQlef t-chest seq 14 6.7 ± 0.6 < .01 [140] 
14b sequential shocks RV -*SVC/CS-FSQtel t-chest simult 14 13.2 ± 3.8 
15 Unipolar RV+ - AC - 25 9.3± 4.6 [141] 
16a Sequential RV -*SVC-FCS seq 9 504 ± 73 .001 16.0 ± 4.4 .019 [142] 
16b Active can RV -AC bi 9 348 ± 63 .027 9.6 ± 4.2 .039 
16c SVC RV -.SVC bi 9 399 ± 60 12.7± 43.7 
"mean" 12.2 ± 3.8 
Table 3.3: Reported performance of electrode configurations in humans. RA = right atrium, RV = right ventricle, SVC = superior vena cava, 
AC = active can pulse generator, SQ = subcutaneous patch (with subscript indicating location), CS = coronary sinus and (s) = stored energy. 
Energy data from this data is plotted in Figure 3.1. p values are between value on row and values below and/or above. p=NS for resistance. 
CAD 
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First, consider each individual investigation. Gold et al (Investigation 01) 
reported a study where the implanted electrodes were a spring coil in the mid 
right atrium and a large extra-pericardial patch over the left ventricle [130]. 
They found biphasic waveforms lowered energy by 30% and voltage by 15% 
compared to monophasic. Resistance was unchanged and energy changed by 
approximately the square of the voltage ratio, which agrees with the relation-
ship (E = V2 / R) expected for resistive materials. 
Schwartzman et al (Investigation 02) found DFT energy was 34% lower 
for a subscapular compared to a pectoral SQ patch when used with a RV 
and SVC electrode, though there was no significant difference in voltage or 
resistance [131]. This result is surprising as either resistance, voltage of both 
should have changed with energy. The best explanation for this is that the 
uncertainty in the resistance and voltage values meant changes could not be 
resolved. 
Swartz et al (Investigation 03) also investigated SQ patch position, finding 
that the DFT energy was 18% less in the subscapular than the mid-axillary 
position, when used with a RV and either a SVC or CS electrode [129]. They 
also found approximately 22% higher DFT energy with sequential than simul-
taneous shocks. 
Bardy et al (Investigation 04) compared an RV (anode) and AC electrode 
configuration to one with an additional anode in the coronary sinus, and sug-
gested they had found a small decrease in DFT energy and voltage [132]. 
However, their results suffered from low resolution, indicated by their high p 
values and their results were not conclusive. 
In Investigation 05, the results of Bardy et al again suffered from a high 
degree of uncertainty. They were unable to distinguish between the DFT 
voltage and energy for 65% and 50% tilt waveforms, applied through an RV 
electrode to pectoral active can configuration to 15 patients. 
Strickberger et al (Investigation 06) looked at the effect of electrode polar- 
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ity using a transvenous two-electrode system. They found that DFT energy 
was raised 40% if the proximal (RV) electrode was the anode rather than the 
cathode, while the resistance was unchanged. 
Saksena et al (Investigation 07) compared the DFT in two large groups of 
patients implanted with either epicardial or endocardial electrodes and found 
that mean DFT energy was 33% less in the endocardial group. They found, 
though, that sudden death incidence was comparable for both groups, but 
perioperative mortality (5.5% epicardial, 0.3% endocardial) was reduced with 
endocardial leads. 
Block et al (Investigations 08 and 09) looked at defibrillation using a two-
electrode transvenous system with and without a SQ patch and with mono-
and bi-phasic waveforms. They found that DFT energy was reduced 25% using 
a SQ patch and 35% using a biphasic waveform, and that a single transvenous 
lead was effective in 90% of patients while transvenous-SQ was effective in 
100% of patients. 
Bardy et al, Venditti et al, Leitch et al and Bardy et al (Investigations 10, 
11, 12 and 15) found DFT energy for transvenous, epicardial and RV-AC 
configurations. Their individual results are difficult to compare because they 
were not controlled experiments within a single investigation. It is interesting 
though that the transvenous results (11.1 and 14.0J) were higher than the 
epicardial result (8.6J), which opposes the finding of Saksena et al in Investi-
gation 07. 
Saksena et al (Investigation 13) compared SQ patch position for a three-
electrode RV to RA and SQ system. Compared to left infraclavicular and 
apical-cardiac positions, an infra-axillary position was found to reduce DFT 
energy and voltage by 29% and 15%, respectively. 
Hsia et al (Investigation 14) compared simultaneous and sequential path-
ways using a RV to (SVC or CS) and SQ patch configuration. They found that 
the DFT energy was reduced by 50% for sequential compared to simultaneous 
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shocks. This is at odds with Investigation 03 where DFT energy for sequential 
shocks increased by 22%. 
Zardini et al (Investigation 16) compared a three-electrode transvenous 
system (RV to SVC and CS) with sequential pulses and two biphasic two-
electrode systems (RV to SVC and RV to AC) with biphasic pulses. The active 
can configuration performed best, while the three-electrode system performed 
the worst, requiring 67% greater energy and 45% greater voltage. The three-
electrode sequential pulsing pathways were similar and may not have been of 
great benefit compared to biphasic pulses, while the relatively large surface 
area of the active can configuration could account for its superiority over the 
SVC electrode configuration. 
Using data from the table, it is possible to compare configurations, but 
only within an individual investigation. Although tempting, it is difficult to 
compare energy and voltage data between studies because of differences in 
experimental methods and subjects. For example, in an (unrelated) experi-
mental study—using a RV transvenous coil and LV epicardial patch (14cm 2 ) 
in pigs—the defibrillation energy for 50% and 90% probability of success was 
reported as 9.0 ± 0.6 and 16.2 + 2.1J, respectively, indicating the large vari-
ation in results corresponding to a change in this variable alone [143]. Also, 
electrodes with the same description (e.g. RV endocardial) may be quite differ-
ent in size, shape and location. Despite these difficulties, there are interesting 
observations that can be made. 
In discussing the results in Table 3.3, first consider the column of energy 
data (which is presented graphically in Figure 3.1 as bars of mean ± standard 
deviation) and the column of p values. The standard deviation of most of 
the results was relatively large at approximately 5J, compared to the means 
at approximately 13J, but in general, in each study the numbers of patients 
and statistical techniques used ensured the mean values of energy for different 
treatments were clearly differentiated, as evidenced by the low (< 0.01) p values 
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Figure 3.1: Minimum energy (mean + standard deviation) for defibrillation in 
humans for various electrode configurations (data from Table 3.3). Dotted line 
indicates mean energy. 
in most of the studies. Exceptions were studies 04, with p values for voltage 
and energy of 0.37 and 0.39, respectively, even though there were relatively 
large differences between mean values, and 05 (p's of 0.67 and 0.17), though 
in this case differences between means was relatively small. 
Two studies, 03 and 14a, had standard deviations that were relatively low 
(< 1.5J). The reasons for low standard deviation in these studies is poten-
tially of great interest. For the electrode configurations and waveforms used, 
thresholds were very similar between patients and were inherently predictable. 
The reasons for this behaviour may be connected to the mechanics of defibril-
lation. It is interesting that the configurations with small standard deviations 
had two transvenous electrodes (RV and SVC/CS) and a subcutaneous patch 
(though the other configurations of this type (02, 04b, 08b, 09, 13) did not 
have small standard deviations). 
These published clinical results show a quite bewildering array of appar-
ently unrelated results where often one study seems to contradict another, but 
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when taken individually the results mostly seem logical. 
3.4 Discussion 
This chapter has reviewed relevent modelling literature and clinical studies of 
defibrillator performance. Recently, a number of finite element models have 
been presented, mainly in conference proceedings rather than in refereed jour-
nals. Although, in general, they are satisfactory models, they all are subject 
to disadvantages of the finite element method. The disadvantages include: 
the necessity to generate a mesh throughout the torso using volume elements; 
the necessity to use a sufficiently fine mesh in critical regions, such as near 
electrodes or in regions where the conductivity changes rapidly, to ensure con-
vergence of iterative methods and accurate solutions; the necessity to generate 
new meshes for different electrode configuration or torso geometry; the neces-
sity to use iterative methods to solve large problems which can lead to diffi-
culties in ensuring convergence and accuracy of the solution. Some of these 
disadvantages may be a significant handicap in certain circumstances. 
The boundary element model presented in this thesis avoids these disad-
vantages. The surface meshes are relatively easy to construct and may be 
easily refined in critical areas. The solution is obtained using a direct solver, 
which avoids problems with solution convergence. The solver developed en-
ables different electrode configurations to be solved without the need to repeat 
the majority of the calculations, leading to relatively quick optimisation of 
electrode configurations. 
The main advantage of the finite element models is the ability to include 
detailed anisotropy. This would be a significant advantage if anisotropy was 
widely distributed throughout the torso. However, torso anisotropy is limited 
to a small number of localised regions and, if desired, can be included in a 
boundary element model by modelling these regions using finite elements or a 
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number of boundary element subregions each having anisotropy in a constant 
direction. 
The results from the clinical studies of defibrillator performance provide 
useful data with which to compare results obtained from models for simi-
lar electrode configurations. This comparison will indicate how closely model 
results compare to clinical results. With knowledge of these results it is pos-
sible to realise how well the boundary element model predicts defibrillator 
performance. The clinical results also show the relatively large range in per-
formance of similar configurations in different studies, the difficulty of con-
ducting well controlled experiments and comparisons between configurations, 
and sometimes the contradiction of results by different studies. This all adds 
to the arguments for modelling defibrillator configurations. Modelling allows 
the variables to be controlled and for clear distinctions to be made between 




The numerical methods that may be used to solve the modelling equations 
for the electric field in the torso include the boundary element, finite ele-
ment and finite difference methods. Models based on both the boundary and 
finite element methods were implemented. The boundary element solution 
method was implemented in original software after discretisation of the gov-
erning mathematical equations. The finite element method was implemented 
using a commercial package. 
In the models, human tissue was considered to be a volume conductor 
with electrical conductivity that was purely resistive. This followed from the 
assumption that defibrillation waveforms do not induce significant capacitive 
or inductive effects in human tissue, as discussed in Section 3.2 (page 30). 
The mathematical basis of both models was that the electric field in the 
torso was governed by Laplace's equation, 
V • (kVu) = 0, 	 (4.1) 
where u is the potential and k the conductivity tensor. Boundary conditions 
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were as follows: on the surface of the torso, 
	
Vu - n = 0, 	 (4.2) 
where n is the vector normal to the surface; on the surface of electrodes, 
u = e(x,y,z), 	 (4.3) 
where e describes the electrode positions and potentials. 
4.2 Boundary Element Method 
In the boundary element method, elements divide the torso into regions of con-
stant conductivity. To apply this method, elements of the torso were grouped 
into regions where the electrical properties were approximated as isotropic and 
homogeneous. Laplace's equation was applied within each region and interface 
conditions were enforced between regions. 
Within a region, the conductivity was constant and therefore equation (4.1) 
reduces to 
v2 u = o. 	 (4.4) 
If we let 
(4.5) 
be the potential gradient normal to the region boundary, where n is the geomet-
ric normal to the boundary, and u* be the fundamental solution of Laplace's 
equation, then the fundamental equation of the boundary element method can 
be written (based on a weighted residuals formulation) as [144] 
u i + I uedr = I qu*dr, 	 (4.6) 
r 	r 
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where r is the boundary and the point i is within the region. For three-
dimensional problems, the fundamental solution is 
1 
U = — 
47rr 
and 
ate OU * Or 	1 Or q* = 	= 	= 
an 	Or an 	47rr2 an 
where r is the distance from point i to the boundary. Equation (4.6) is valid 
for point i within the region, but for point i on the boundary of the region we 
get 
ciu i 	uedr =j qu*dF, 	 (4.9) 
where ci is a coefficient to be determined. 
The boundary element method involves numerically solving equation (4.9) 
to find the potential and gradient over the region boundary. The boundary 
of the region, r, is therefore divided into N discrete elements, F 3 , resulting in 




E uiq*dF = fr E j= j.1 i *dr. 	 (4.10) 
The boundary discretisation was done using quadrilateral elements. It 
would have also been possible to use triangular elements or elements of more 
complex shape (curved, for example). The variation of potential and normal 
gradient was assumed constant over each element and equal to the value at 
the mid-point. Again, other schemes, with linear or quadratic variation, for 
example, could have been used. Constant quadrilateral elements were cho-
sen primarily for ease of implementation, both computationally and in mesh 
construction. The constant variation of potential did present challenges in 
accurately calculating potential gradient on elements in postprocessing calcu- 
(4.7) 
(4.8) 
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lations. 
For constant elements, u; and q; may be taken out of the integrals and 
= 1/2. Therefore, equation (4.10) becomes 
1 -1--EU• 	q *dr =Eqj ri u*dr. 
3=1 	rj 2 	.  ..7=1 
(4.11) 
The remaining integrals apply only over individual elements and may be cal-
culated numerically using two dimensional Gaussian quadrature rules. The 
element integration implementation is detailed in Appendix B and is similar 
that implemented by Kilpatrick and Johnston [88]. The result of integration 
over the elements can be written as I/ and G terms where 
= 	q*dF, 	 (4.12) 
ri 
and 
Gia = 	%eV'', 	 (4.13) 
Jr, 
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Hi; = ki; 	for i j 	
(4.16) 
Hii = 	for i = j 
This results in a set of equations that can be written in matrix form as 
Hu = Gq, 	 (4.17) 
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where H and G are both square (N x N) matrices and u and q are vectors 
(of length N) of potential and potential gradient on each boundary , element. 
Matrix equations of type (4.17) were derived for each region in the model. 
These equations were combined using interface conditions between connected 
regions. This resulted in a set of equations describing the electric field through 
the whole torso. 
The interface boundary conditions between connected regions were com-
patibility of voltage and continuity of current. That is, if ki , ui and qi were, 
respectively, the conductivity of region i and the potential and normal gradient 
on the boundary of region i, then on a common boundary between regions 1 
and 2, 
UI = U2 	 (4.18) 
and 
= — k2 q2 . 	 (4.19) 
Boundary conditions arose due to no current flow across the outer region 
boundary or across electrode surfaces (Neumann boundary condition), and 
due to applied potential on electrodes (Dirichlet boundary condition). 
Applying the boundary conditions resulted in matrix equations that fully 
described the problem. The assembled matrix equations, though, had a mix-
ture of known and unknown values of u and q on each side. The equations 
were therefore rearranged to form a global matrix equation: 
Ax = b. 	 (4.20) 
This consists of: a square matrix, A, of known values that were dependent 
on the geometry; a vector, x, of unknowns; and a vector, b, of known values 
that were dependent on the geometry and the boundary conditions. A detailed 
description of the assembly of the matrix equations is given in Appendix A. 
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Equation (4.20) was solved to yield the unknown values of u ; and qi con-
tained in x. The solution method employed was Gaussian elimination I. 
After solution of equation (4.20), the potential u and normal gradient q 
were known on each boundary element. Values of u and q elsewhere in the 
torso, such as at an internal point i, were found using the known boundary u's 
and q's applied to the integral equation 
— 	qu*dr — uq*(111 	 (4.21) 
Equation (4.21) is simply a rearrangement of equation (4.6). At the point i, 
the equation describing the potential gradient in a direction x was found by 
differentiating equation (4.21) to get 
auy 	au* ,, 	aq* 
qx = (— = q—au. —
Ox 
 
Jr ax 	Jr Ox 
(4.22) 
with similar expressions for the y and z directions. Equations (4.21) and (4.22) 
were discretised in a similar way to equation (4.10) and the values of ui, qxi , 
q iy' and qiz were found by direct substitution of the known boundary potentials 
and normal gradients. 
The gradient on a boundary was calculated by adding the vectors describ-
ing the normal and tangential gradients. The normal gradient was known 
from the initial boundary element solution. The two tangential gradients were 
calculated using an approximate method where the known element potentials 
where linearly interpolated onto the element nodes to get nodal potentials, 
which were used with the element geometry to calculate the gradient. 
1 The implementation of Gaussian elimination used a novel method that reduced the 
numerical processing requirements when solving multiple problems. Also, by using efficient 
out-of-core techniques, any size problem could be solved, subject only to limitations in disk 
space and processing time. (Refer to Section 5.3) 
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4.3 Finite Element Method 
To apply the finite element method, elements of the torso were again grouped 
into regions where the electrical properties were approximated as isotropic 
and homogeneous. Laplace's equation (equation (4.1)) and the boundary con-
ditions from equations (4.2) and (4.3) were then applied to the complete torso. 
The electrical conductivity varied within the torso so the conductivity term 
was retained in Laplace's equation. The governing equation was therefore 
V • (kVu) = 0, 	 (4.23) 
where k was the conductivity tensor and u the potential. 
Consider now Green's theorem: 
Iv V. (kV) dV = — f k V. V dV 	k 3  is an (4.24) 
where V is a volume, S is the bounding surface and n is the geometric normal 
to the surface. Green's theorem holds throughout V for functions ck and tk. If 
= u, then equation (4.23) can be substituted into equation (4.24). The left 
hand side vanishes, resulting in the relation: 





In FIDAP, this equation is discretised forming a set of matrix equations. The 
type of elements used were 8 node linear bricks. For these elements, the matrix 
components were evaluated using three dimensional Gaussian quadrature. The 
resulting set of equations were solved using FIDAP's conjugate gradient solver 
yielding values for potential at each node. 
Details of the discretisation of equation (4.25) have not been reproduced 
here since they are described in detail in the FIDAP manuals. Also, many 
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finite element method texts are available that describe the method (for exam-
ple, [145]). 
Chapter 5 
Implementation of Numerical 
Methods 
5.1 Introduction 
This chapter discusses implementation of the numerical methods of Chapter 4. 
The implementation involved discretisation of the torso and embodyment of 
the discretised equations into computer code. A number of steps were therefore 
involved in the implementation: the torso geometry was constructed; boundary 
conditions and electrodes were specified; the governing matrix equations were 
built; the equations were solved to find the unknowns; and postprocessing 
was done to calculate potentials and gradients inside regions and gradients on 
boundaries. 
It should be noted that the implementation was performed for Silicon 
Graphics Iris Indigo XZ 4000 1 or Sun 4.3302 computers with 96 megabytes 
of random access memory. Software was developed using the C programming 
language. Solution times given in the text are for programs running on the 
Indigo, which was the faster of the two computing platforms. 
1 Silicon Graphics, Inc., Mountain View, California, U.S.A. 
2 Sun Microsystems Computer Corporation, Inc., Fremont, California, U.S.A. 
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5.2 Torso Construction 
One human and one sheep torso were constructed for use with the boundary 
element method and one human torso was constructed for use with the finite 
element method. This allowed modelling of realistic electrodes, investigation 
of new electrode configurations, comparison of model and experimental results 
and comparison of model results with published results from numerical and 
clinical studies. It was desirable for the two human torsos to be as similar 
as possible because boundary element results were to be compared to finite 
element results as part of the validation of the boundary element model. Con-
sequently, the human torso was first constructed from boundary elements, then 
this was used as the basis for the finite element torso. 
Boundary element torsos 
The available data for the construction of the human boundary element torso 
included a series of 25 CT scans at lcm spacing of a normal male and a series of 
11 MRI scans at lcm spacing of a normal female. Torso geometry was obtained 
from the CT scans while heart geometry was obtained from the MRI scans. 
Although this was not the ideal of having all scans from the same person, the 
torso and heart were compatible and only slight modification to the shape of 
the lungs was required when the heart was placed inside the torso. The outline 
of each major structure in the torso was digitised from the scans using a Hipad 3 
digitising pad. The digitised outlines were then used to build three dimensional 
surface meshes representing the structures. The structures digitised were the 
heart, venous and arterial blood cavities, major vessels, lungs, spine, sternum 
and the third, fourth, fifth and sixth ribs on the left side (Figure 5.1). All 
other torso components were grouped together as torso tissue. Each structure 
3 HipadT " Digitising Pad, Bausch and Lomb, Austin, Texas., U.S.A. 
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Figure 5.1: Slice through the torso showing regions in the model 
represented one region in the model. 
The data for the construction of the sheep boundary element torso was ob-
tained from CT scans of a sheep taken specifically for this purpose. The sheep 
was a normal Australian cross-bred ewe. The sheep's torso was CT scanned 
at 1cm intervals resulting in thirty three images from neck to abdomen. The 
boundaries of the torso, spine, sternum, lungs, epicardium and major vessels 
were digitised from the scans, while the endocardial cavities were digitised 
from lcm sections taken through the explanted heart. The torso structures 
were then built from the digitised boundaries using quadrilateral elements. 
The sheep model was therefore similar to the human torso model although the 
aorta and inferior vena cava were not fully defined in the sheep model. 
The structures in the human and sheep boundary element torsos were built 
using the pre- and post-processing package Patran 4 and routines developed to 
partly automate the building. The building procedure involved creating nodes 
around the digitised boundaries at appropriate points. The nodes were then 
connected on and between slices to create quadrilateral elements defining the 
4 Patran was from PDA Engineering, Costa Mesa, California 
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surface of each region. 
A number of strategies were used in the building process. One strategy in-
volved spacing a constant number of nodes evenly around each digitised bound-
ary. Nodes on adjacent boundaries were then connected to form the mesh. The 
use of transition elements were sometimes combined with this strategy. Tran-
sition elements were quadrilateral elements that were constructed such that 
adjacent boundaries could contain different numbers of nodes. 
Another strategy was used for regions with boundaries that were reason-
ably regular in shape. After digitising the scans, an open-ended cylindrical 
surface mesh was constructed that had a layer of nodes corresponding to each 
digitised slice. The cylindrical mesh was placed over the digitised points and 
then shrunk onto them. This mesh was then smoothed by maximising the 
corner angles of the elements. The mesh was then modified manually, if neces-
sary. In both of these steps, element node positions were moved to alternative 
digitised points to preserve the integrity of the region shape, rather than allow 
unrestricted movement of the nodes. The open ends of the mesh were then en-
closed manually. Following this, a second mesh could be shrunk over the first, 
if desired. The second mesh was shrunk until its element nodes were about 
to enter the region defined by the first mesh. This allowed a high density 
mesh to be created with nodes that were not constrained to lie on the same 
cross-sections as the original digitised points. The second mesh could also be 
smoothed, if necessary. 
Patran was used to modify or to add details to each mesh, or sometimes to 
construct portions of the surface that were difficult to create by other means. 
Patran was especially useful in creating transition regions, where the region 
shape changed rapidly or where two parts of a region were connected after being 
meshed separately. Another use of Patran was the construction of geometry 
using splines or parametric cubic curves fitted through the digitised points, 
then creation of the mesh from this geometry. 
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Heart Lung Blood Fat Bone Thoracic tissue 
556 	2000 	150 2500 	oo 	435 
Table 5.1: Values of resistivity (ftcrn) used in the model. 
The final form of the surface meshes representing the human and sheep 
torso structures are shown in Figures 5.2 (and Plates 1 and 2) and 5.3. In 
total, approximately 6000 quadrilateral elements were used in the human torso 
and 7000 in the sheep. The conductivity of each region was set to the values 
in table (5.1). These values were taken as representative from the literature, 
as discussed in section 3.2. 
A variety of methods were used to represent electrodes (Figure 5.4). Elec-
trodes in the venous blood were represented as additional regions within the 
blood and were created using Patran. The boundary condition applied was a 
constant potential over their surface. Epicardial electrodes were represented 
by an additional region over the epicardium. They were created by defin-
ing elements on the epicardium that were to be covered and then running a 
purpose-written computer program that automatically created the electrodes. 
If necessary, the lung surfaces were displaced to make room for the epicardial 
patches. The boundary conditions applied were constant potential on the cov-
ered epicardial elements and zero normal gradient on the sides and back of 
each patch. Subcutaneous patches were represented simply by boundary con-
ditions on the torso surface. The boundary condition applied was a constant 
potential on selected elements. 
Finite element torso 
As previously mentioned, it was desirable for the finite element torso to be 
as similar as possible to the boundary element torso. Consequently, the fi- 
nite element torso was constructed directly from the boundary element torso. 
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Figure 5.3: Components of the sheep torso discretised into boundary elements 
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U = const 
Transvenous 	 Epicardial 	 Subcutaneous 
Figure 5.4: Types of electrodes implemented in the boundary element model 
The boundary element torso was used to establish the location of the torso 
structures. 
The first stage in construction was to specify the locations of the elec-
trodes. An extremely coarse finite element mesh was then constructed that 
encompassed the whole torso using 8 node brick elements (Figure 5.5(a)). The 
construction was such that there would eventually be a high density of nodes 
around the specified electrodes. The next stage involved splitting each brick 
element into 8 smaller bricks, Figure 5.5(b). The sub-division process was 
then repeated Figure 5.5(c). After six subdivisions the desired node density 
was achieved. The mesh density was such that each major feature in the 
boundary element mesh was adequately resolved using finite elements. The 
mesh was related to the boundary element torso by comparing the location of 
the centroid of each brick to the positions of the boundary element structures. 
Those bricks outside the torso were removed. Those inside were assigned the 
conductivity of the corresponding structure. A cross-section through the final 
finite element mesh with the boundary element mesh superimposed is shown 
in Figure 5.5(d). A total of 159952 nodes and 153082 elements were used. 
Boundary conditions were applied by finding the finite element nodes that 
corresponded to the electrodes in the boundary element model and setting the 
potential on those nodes. The boundary condition on the torso boundary was 
CHAPTER 5. IMPLEMENTATION OF NUMERICAL METHODS 	58 
(a) (b)  






Figure 5.5: Cross-section through the (a) first, (b) second, (c) third and 
(d) sixth (and final) brick meshes during construction of the finite element 
torso. On the final brick mesh, bricks outside the torso have been removed and 
the boundary element mesh superimposed 
zero normal flux. An exploded view of the finite element torso is shown in 
Figure 5.6. 
Left lung 
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5.3 Boundary Element Method Implementa-
tion 
Building equation matrices 
The boundary element implementation involved building matrix A and vector 
b from equation (4.20). The first step in building A and b was to build sub-
matrices by applying equation (4.17) to each region of the discretised torso. 
The sub-matrices were combined using equations (4.18) and (4.19) then rear-
ranged with the unknown potentials and gradients were on the left hand side 
and the known values were on the right hand side. The matrix on the left was 
A, while the matrix on the right was multiplied by the known values to form 
b. 
The block structure of A is shown in Figure 5.7. The size and structure 
of A determined the solution techniques employed. The dimension of A was 
typically around 10000 x 10000. Also, A contained blocks of values for each 
region in the torso. Blocks representing the torso tissue, heart and venous 
blood regions were relatively large because of the number and complexity of 
surfaces in those regions. The torso tissue and heart blocks were particularly 
large. The venous blood only enclosed electrodes, so the blocks for this region 
were not particularly large because of the relatively small number of elements 
associated with the electrodes. 
The size of the large individual blocks in A could be reduced by adding 
additional surfaces inside the torso. The surfaces would be constructed specif-
ically to reduce the number and size of subregions within the torso tissue and 
heart. These would result in A becoming more narrowly banded which could 
potentially reduce the computation time. 
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Figure 5.7: The block structure of matrix A in equation (4.20) 
Solving the matrix equations 
The matrix equations derived from equation (4.20) were solved using Gaussian 
elimination. This involved converting A to upper-diagonal form then back-
substituting to find the unknowns x. Although the dimensions of A were 
relatively small (compared, say, to a finite element implementation), it was a 
relatively full matrix and typically consumed approximately 500 megabytes or 
more of storage space. This was more storage than was available in random 
access memory, so it was necessary to store A on disk and to use out-of-core 
techniques when performing the Gaussian elimination. A specific out-of-core 
method was developed to ensure an efficient solution. The method involved 
manipulating matrix elements in the same order in which they were stored. 
This allowed large blocks of the matrix to be read from disk, processed, then 
returned to disk. This was much more efficient than alternative methods of 
processing the matrix elements. 
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AINO 
A 
Figure 5.8: Matrix A and vector b from equation (4.20) after processing as 
far as possible to upper-diagonal form before the transvenous electrodes were 
defined 
solution to be almost fully calculated then used as the basis of calculations for 
new electrode configurations. This feature was especially advantageous when 
considering different transvenous electrodes and often resulted in substantial 
savings in processing effort and time. In this procedure, most or all of the torso 
structure was defined, along with any invariant electrodes, with appropriate 
use of subregions, and this part of the problem was processed to the stage of 
equation (4.20). The aim was to build A so that all the pre-determined parts 
were in the upper rows and all the new parts were in the lower rows. Matrix 
A was turned into upper-diagonal form but only down to the last known row. 
At this point processing was stopped and the matrix saved, along with the 
appropriately modified vector b and a string of numbers indicating the status 
of the calculation (Figure 5.8). In many cases, most of the processing of the 
problem had been encountered by this stage. For each variation of the problem 
to be considered, the unknown parts of the torso and electrodes were defined 
and the remaining rows of A and b calculated. The process of converting A 
Read n rows of A into memory from "diskfile" 
Convert to upper-diagonal form and append result to file "upperdiag" 
Sequentially read the remaining rows from "diskfile", 
zero all columns that share a diagonal with the 
converted rows and store result in "tempfile" 






























     
 
Find unknowns x using backsubstitution with the values 
in "upperdiag" and in the modified "vector.b" 
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( Stan ) 
For each row of A and b , calculate values then store the row 
from A in file "diskfile", and the row from b in "vector.b" 
End 
Figure 5.9: Procedure for solving equation (4.20) 
to upper-diagonal form was then resumed and the final solution found. This 
procedure allowed, for example, different transvenous electrodes to be tested 
in the one torso, and was used to relatively quickly optimise electrode type 
and position. The solution procedure is summarised in Figure 5.9. 
Postprocessing 
The postprocessing done after solving the matrix equations included the calcu-
lation of potentials and gradients at points inside regions and the calculation 
of the boundary potential gradients. Internal potentials and gradients were 
found by calculating matrix elements for the discretisation of equations (4.21) 
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and (4.22) then multiplying out the matrix elements with the known boundary 
values. These were then stored on disk and could then be used in calculations 
for different electrode configurations if none of the region elements changed. 
This avoided the need for recalculation of the matrix elements and greatly 
reduced the calculation time for the new configurations. 
The potential gradient.on the boundary of the regions was calculated as the 
vector sum of the components of the gradient. There were three components 
to the gradient at the boundary, one in the normal direction and two in the 
tangential directions (Figure (5.10)). The component in the normal direction 
was already known from the solution of equation (4.20). The components in 
the tangential directions were not already known and had to be calculated. 
This involved using an approximation because it was not possible to calculate 
the tangential gradients directly using the boundary element method. This 
was because the boundary element discretisation assumed a constant potential 
over the surface of individual elements. Therefore, the tangential component 
of the gradient on the surface of the individual boundary elements was zero. 
However, the potential varied as step functions between adjacent elements, so 
on this scale the tangential gradient was not zero. The tangential gradient 
was calculated by fitting linear approximations to these step functions. To 
do this, the potential at the four nodes of each element was calculated by 
applying a spatial weighted average to potentials on adjacent elements. Then 
the tangential components of potential were calculated by linearly interpolating 
the nodal potentials. 
Solution speed 
The speed at which a solution was obtained using the model was of interest, 
particularly when considering the practicality of the solution method. With 
the full human torso geometry, the time taken to solve for one electrode con-
figuration took a total of nearly 69 hours. However, each modified electrode 
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1 
Figure 5.10: Normal and tangential components of gradient on a boundary 
element. 
configuration only took approximately 2 hours to solve. The exact durations 
depended on the number of elements used to define the electrodes and on the 
extent of any mesh refinement. 
The solution time was proportioned as follows for a typical solution. Cal-
culating the geometry matrices A and b from equation (4.20) for all regions 
other than for venous blood and transvenous electrodes took approximately 
11.5 hours. Converting matrix A to upper-diagonal form, as far as possible 
without the venous blood and transvenous electrodes being defined, took a fur-
ther 54 hours. This made a total of 65.5 hours. With the electrodes defined, 
construction of the remainder of matrix A took 42 minutes and completing 
the conversion of matrix A to upper diagonal form took an additional 1 hour 
18 minutes. Back-substitution to find the vector x of unknown boundary po-
tentials and normal gradients took only a further 1 minute. Calculation of the 
potential and gradient at points inside the myocardium was done by first cal-
culating the matrix relating the internal potentials and gradients to those on 
the boundary, taking 1 hour 18 minutes (coincidentally, the same duration as a 
previous calculation). This matrix was multiplied with the boundary values to 
obtain the potential and gradient at the internal points, taking approximately 
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1 minute. Subsequent internal point calculations for other electrode configura-
tions used this same matrix and took only 1 minute. Calculating the gradient 
on the boundary, using the element normal gradients and the tangential gra-
dients, calculated from interpolating the element potentials onto the element 
nodes, took approximately 5 minutes. 
The solution time could be substantially reduced if better use was made of 
subregions to reduce the size of the blocks in A and make it a more narrowly 
banded matrix. However, this may impact on the versatility of the model as it 
would make the mesh more complicated and therefore more time consuming 
to generate and more difficult to change. 
Chapter 6 
Validation of Numerical 
Methods 
6.1 Introduction 
There were a number of issues to consider when validating the model. These 
were conveniently separated into two groups: one concerning the implementa-
tion of the numerical methods and other the difference between the model and 
reality. The validation of the numerical methods is considered in this chapter. 
The numerical methods were validated by comparing the model with results 
from analytical and finite element models. Comparison with an analytical so-
lution was to verify that the code was correct and to indicate the accuracy 
of the method. Comparison with finite element implementations was to more 
completely verify the code using realistic torso and electrode configurations. 
The closeness to reality is considered in the next chapter, where validation 
against experimental and clinical results is presented. 
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6.2 Comparison with Analytical Solution for 
Concentric Spheres 
A concentric spheres model was used that consisted of four spheres: the outer 
sphere represented the chest and was configured as a subcutaneous patch elec-
trode (+100V), the next sphere represented the epicardium, the next rep-
resented the endocardium and the inner sphere represented an endocardial 
electrode (-100V). Each sphere was constructed from 600 elements, the en-
tire surface of both the outermost and innermost spheres were configured as 
electrodes to facilitate a simple analytic solution and the regions between the 
spheres were given the conductivity of body tissue, myocardium and blood. A 
section through the center of the spheres is shown in Figure 6.1. The radius 
of the spheres was 40, 30, 20 and lOmm. 
The analytical solution for this problem is derived by first considering that 
the current flowing between spheres i and i + 1 is 
iii+i 	471- kii+ 1 ( ,ui+i — u i ) 
1/r1+i — 1/r i 
and that the total current flowing through each region is the same for each of 
the three regions. Also, the potential in the region between spheres i and i + 1 
at a radius r is 
u r = 	+ 	
I
. (1/ri+ i — 1/r1) 
47- 14+ 1 
These expressions can be used to find the potential anywhere between the inner 
and outer spheres, while the potential gradient may be found by differentiating 
equation (6.2), so that the gradient at r is 
au r 
qr = Or 	4irk:+1 r2 (6.3) 
(6.1) 
(6.2) 
• Results are given in Table 6.1 and Figure 6.2. Table 6.1 gives values for 
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(+100V) 	• 
Figure 6.1: Slice through the center of the concentric spheres model 
Radius Potential Potential gradient 
(mm) Model Analytic Error' Model Analytic Error 
(V) (V) (%) (V/mm) (V/mm) (%) 
endocardium 20 -26.753 -26.640 0.06 13.735 13.653 0.60 
myocardium 25 28.975 27.973 0.50 8.756 8.738 0.21 
epicardium 30 64.255 64.382 0.06 6.153 6.068 1.40 
°with respect to the anode-cathode voltage of 200V 
Table 6.1: Results from the concentric sphere model 
the potential and potential gradient on the epi- and endocardium and in the 
myocardium and it is evident that the model closely replicates the analytic 
solution. The errors that arise are small and occur mainly because the analytic 
solution uses spheres of perfect shape, whereas the model uses spheres with 
surfaces that are approximated by flat quadrilateral elements. 
Figure 6.2 shows the potential and potential gradient along a radius from 
the inner to the outer sphere. Extremely good agreement is observed between 
the analytic and model solutions. The slight loss of accuracy that can be 
observed in the gradient for radii close to the surface of each sphere, though 
a characteristic of the BE method, can be reduced by applying appropriate 
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6.3 Comparison with Finite Element Solu-
tion for a Cube 
The concentric spheres results verified the model for regularly shaped elec-
trodes and for different conductivity material but not for electrodes covering 
only part of a surface. This latter case is important because high potential 
gradients are developed near these electrodes and may result in relatively large 
numerical errors. Consequently, the model was also tested using a cube with 
surface patches and the results were compared to a FE solution. Some of 
the nodes on the surface of the cube were set to +100V and some were set 
to —100V so as to simulate two surface patches. The patches were on oppo-
site faces of the cube, were square and occupied 1/25th of the face area. It 
was expected that the accuracy of the BE and FE solutions would increase as 
the number of nodes in the cubes were increased so a number of cubes were 
constructed to test this. 
Figure 6.3 shows a cross-section through the three FE meshes modelled. 
The elements were 8 node bricks. The first mesh had 1037 nodes, the second 
had 7417 nodes and the third 56177 nodes. They were constructed by creating 
the first mesh, then splitting the elements in this to form the second mesh, 
and splitting again to form the third. Each split resulted in eight bricks being 
formed from each original brick. Four BE meshes were used. These were 
constructed of quadrilateral surface elements. There were 150, 276, 492 and 
948 nodes in the four meshes. 
Figure 6.4 shows the potential along a line joining the centers of the patches 
for both the FE and BE solutions. The solutions were very different for the 
coarse meshes, but converged as the meshes were refined. As they converged, 
FE potentials decreased while BE potentials increased in value, indicating 
that the exact solution was probably spanned by the original coarse solutions. 
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Figure 6.3: Finite element meshes (a) coarse, (b) each element split once (c) 
each element split twice. Surface nodes beneath the markers are set to the 
potentials indicated. 
Convergence of the solutions indicated the error, arising mainly from high 
potential gradients near the patches, became relatively small. As can be seen 
from Figure 6.3, the FE meshes were made somewhat more dense near the 
patches to try and overcome this problem, as were the BE meshes. 
6.4 Comparison with Finite Element Solu-
tion for Realistic Torso and Electrodes 
Two different models, the BE model and a FE model, were used to calculate 
the potentials in the myocardium for a realistic thorax and the results were 
compared. The thorax for the BE model was as described in section 5.2, 
without ribs. The thorax for the FE model was generated from the BE model 
and contained approximately 160, 000 nodes, with a high density of nodes near 
the electrodes. The construction of the FE thorax is described in section 5.2. 
Standard Enguard atrial and ventricular endocardial electrodes, located 
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BE potentials (V) 
Figure 6.5: Comparison of FE and BE results for endocardial electrodes in the 
RV and SVC (RE = 2.8%) 
in the superior vena cava and right ventricle, respectively, were used in both 
models. (Enguard sensing/pacing defibrillation leads are manufactured by 
Telectronics Pacing Systems. Details of these leads are given in Section 8.2 
and Appendix D.) The potential at 1152 locations in the myocardium was 
found for each model and the models compared by comparing these values. 
A plot of FE against BE potential at each point is shown in Figure 6.5. 
Ideally, the points would lie along the a line through the origin with a slope of 1. 
Actually, the points were scattered closely about this line. The least squares 
regression line through the points had a slope of 1.0125 and a y-intercept of 
-0.2133. The average relative error between the FE and BE potentials was 
2.8%, indicating very good agreement. 
This result means that the use of the model with a realistic body was valid 
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and that even with the complex geometry of the body numerical errors were 
small. 
Chapter 7 
Validation in Sheep and 
Humans 
7.1 Introduction 
The previous chapter dealt with validation of the numerical methods used in 
the boundary element model. The conclusion was that the numerical methods 
were implemented correctly and gave accurate solutions. This second chapter 
on validation deals with the accuracy with which the model predicts the electric 
field in a sheep and the performance of defibrillators in humans. 
The accuracy of the model is determined by the the model's representation 
of reality. There are always some differences for a model of this type, whether 
it be in regard to the structure and properties of the torso, the nature of the 
electrode-torso interface or the criteria that determine fibrillation and defib-
rillation. This validation of the model quantifies the difference between the 
,model and reality by comparing results from the model to measured values 
in humans and sheep. Comparison with experimental results indicated how 
closely the approximations inherent in the model matched reality. Compari-
son with clinical results indicated how well the model results matched a set of 
results from humans. 
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7.2 Sheep Validation 
In this validation, epicardial potentials calculated using a sheep model were 
compared to epicardial potentials measured on a live sheep implanted with 
defibrillator electrodes. The purpose was to verify the capability of the model 
to predict the electric field in a real thorax. 
Experimental apparatus 
The experimental apparatus (Figure 7.1) consisted of a sheep, delivery elec-
trodes, a current source, a multichannel recording device and a heart-sock. 
The sheep was a cross-bred ewe weighing 43kg. There were two (Enguard) 
delivery electrodes of identical dimensions (3mm diameter, 6cm long) which 
were located in the superior vena cava and right ventricle. The two electrodes 
will be termed the anode and cathode, respectively. The current source was 
a 100Hz, 0.80mA constant current source. One source output was connected 
through a resistor (used to verify current) to the anode. The other output was 
connected directly to the cathode. The multichannel recording device was a 
128 channel device for recording potentials with an input range of 0 — 50mV, 
was produced in-house and named "EDAS". Each EDAS channel was oper-
ated at 1000 Hz. The heart-sock was an elastic sock that fitted over the heart 
with 64 electrodes distributed on it that made contact with the epicardium. 
The sock was constructed from a thin, closely-knit woven material. Although 
the material was an insulator, the woven material covered only about 20% 
of the epicardial surface. Considering the relatively good conductivity of the 
fluid bathing the sock, the influence of the heart sock on the electric field was 
considered small compared to other sources of error. 
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47.5 S2 
SVC 
Figure 7.1: Apparatus to recording potentials from sheep 
Experimental procedure 
The experimental procedure was as follows. The sheep was placed on an op-
erating table and anaesthetised. The chest was opened and the heart exposed 
by removing the third rib on the left side and spreading the chest wall. The 
two delivery electrodes were implanted through the Jugular vein. The correct 
positioning of the electrodes was ensured manually by feeling their position 
inside the exposed heart and vessels. The cathode was positioned with the 
tip of the lead in the apex of the right ventricle. The anode was positioned 
in the superior vena cava just above the junction with the right atrium. The 
heart-sock was pulled over the heart (from the apex) such that it covered the 
ventricles. The heart was repositioned, saline added to the cavity and the 
chest wall closed. (The saline used was diluted normal saline with a conduc-
tivity of approximately 40012cm.) With the chest closed, internal suction was 
applied to remove excess saline. The current source was then connected to 
the delivery electrodes and the potentials on the heart-sock electrodes were 
recorded using EDAS. The sheep was then killed, the chest opened and the 
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heart removed. The position of the heart-sock electrodes on the epicardium 
were recorded. The heart was frozen and then sliced from the apex into 1cm 
thick slices. The endocardial surfaces were traced onto paper and the tracings 
digitised. The sheep's thoracic geometry was discretised for use in the model 
as outlined in section 5.2. The same tissue conductivity values were used in 
the sheep model as for the human model. The delivery electrodes used in the 
model were endocardial electrodes of the same dimensions as those used in the 
sheep. 
Results 
The results are presented for the equivalent of a static applied potential field 
of zero on the cathode and 50mV on the anode. The epicardial potentials 
from the sheep model and experiment were mapped onto the epicardial surface 
(Figure 7.2) and plotted against each other (Figure 7.3). 
For the 64 epicardial potentials, the correlation coefficient (CC) was 0.464 
and the average relative error (RE) was 23.6%, with a maximum individual 
RE of 57.9%. Resistance between the cathode and anode from the experiment 
and model were 75.811 and 57.611 respectively, giving a relative error of 31.6%, 
which was of the same order as the relative error in epicardial potentials. 
Discussion 
Both experimental and model-generated epicardial maps had potentials in-
creasing from apex to base with the lowest potentials over the right ventricle. 
However, the maps were visually different. Part of the reason for this was the 
high resolution of the maps. The contour spacing was only 2mV, which was 
just 4% of the applied voltage. The reason for this was that all potentials on the 
epicardial recording electrodes were grouped within the range 6— 19mV. This 
was due to the recording electrodes being spaced relatively uniformly around 
the cathode (which was at OmV) while the anode (at 50mV) was relatively 
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Figure 7.2: Epicardial potential maps (mV) for experimental and model results 
for endocardial electrodes (50mV signal) in a sheep 
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Figure 7.3: Correlation of epicardial potentials for experimental and model 
results for endocardial electrodes (50mV signal) in a sheep 
distant. 
The low error in potentials and the closeness of the resistance match indi-
cate that, on the whole, the field magnitudes are corrects. The difference in 
epicardial patterns may be the result of neglicting myocardial anisotropy in 
the model. 
Potentially, the main sources of experimental error were associated with the 
tissue conductivity values, the sheep torso geometry and the electrode locations 
used in the sheep model. Of these, errors due to uncertainty in torso geometry 
and electrode location were probably the most significant. In particular, the 
exact shape and orientation of the heart was difficult to determine, since it was 
beating when the CT scans were taken and its position was disturbed when 
the heart sock was fitted. 
In regard to the measuring electrodes, the error due to the uncertainty of 
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of the electric field near the electrodes. The error in position of the electrodes 
was estimated as approximately lcm. The average field strength near the 
electrodes was, from the model, approximately 2.5mV/cm. Therefore, the 
potential recorded by the epicardial electrodes was in error by up to 2.5mV 
due to uncertainty in torso geometry and electrode location. 
Improvements to the experiment could include repeating the experiment 
using many sheep with statistical analysis of the results. Also, sheep tissue 
conductivity could be measured in vivo to provide individually matched con-
ductivity values for use in the model. High resolution CT or MRI scans could 
be taken of each sheep to accurately model the sheep torso geometry and the 
exact positions of the electrodes. Electrode position could alternatively be 
found from two x-ray images taken at right angles. 
7.3 Human Comparison 
A comparison was made between results calculated by the model and mea-
sured on humans. Measured values of resistance and voltage at defibrillation 
threshold were obtained from Telectronics Research and Development depart-
ment for 29 patients implanted with standard Enguard right ventricular and 
atrial endocardial electrodes, and for 8 patients implanted with an additional 
subcutaneous patch (28cm 2 ). The patients implanted with subcutaneous elec-
trodes could not be adequately defibrillated with endocardial electrodes alone. 
Predicted values of resistance and voltage at defibrillation threshold were cal-
culated using the model with a single arbitrary human torso geometry (no ribs) 
and the standard Enguard defibrillator electrodes with and without a subcuta-
neous patch. The predicted value of resistance was calculated by dividing the 
applied voltage by the total current. Predicted values were also found for the 
subcutaneous patch configuration with ribs in the model. Thorax geometry 
data for the patients was unavailable, so no attempt was made to individually 
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model patients. 
The clinical and model results were compared by considering the relative 
error between the model result and the mean and individual clinical results. 
The relative *error of the mean clinical result and the model result was a mea-
sure of how close the model result was to the mean of the clinical results. The 
mean relative error between the individual clinical results and the model re-
sult was a measure of the distribution of the clinical results around the model 
result, and reflected the natural variation and experimental errors inherent in 
the clinical data. The relative errors are given in Table 7.1. 
The voltage and resistance values for the endocardial-only configuration 
were plotted in Figure 7.4(a). The model result (53.712 and 447V) was within 
the range and near the centroid of the clinical values (54.1+6.411 and 408±92V, 
mean ±s.d.). Being near the centroid meant the relative error for the mean 
clinical results was low, while the spread of the clinical values meant the indi-
vidual relative error was relatively high. This result supports the premise that, 
for this configuration, the model adequately predicts defibrillator performance 
in a clinical setting. 
The voltage and resistance values for the endocardial-patch configuration 
were plotted in Figure 7.4(b). The model result without ribs (36.811 and 215V) 
was outside the range of the clinical values (46.9 + 5.911 and 400 + 134V, 
mean ±s.d.). The mean relative error was relatively large because of the large 
difference between the mean clinical and model results and was of similar 
magnitude to the individual relative error, which again reflected the large 
spread of the clinical results. Adding ribs to the model brought the result 
(37.811 and 265V) within the range of the clinical values and improved the 
relative error values. This result suggests that ribs should be used in the 
model when considering subcutaneous electrodes. The model was sensitive to 
patch size with a larger patch (78cm2 ) lowering voltage and resistance. 
That the subcutaneous patch model results were not near the centroid of 
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Resistance (Ohms) 
(a) Enguard electrodes in the right ventri-
cle and superior vena cava 
- 
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Resistance (Ohms) 
(b) Enguard electrodes in the right ventricle and superior vena cava and a subcutaneous patch 
Figure 7.4: Comparison of defibrillation voltage and resistance from the model 
and from measurements in humans 
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Electrodes Ribs in 
model 
RE(mean clinical) and model mean 	ical and model REctin 
voltage 	resistance voltage resistance 
RV- , SVC+ no 9.4 0.8 23.4 11.6 
RV- , SVC+, SQ+ no 46.2 21.6 53.2 24.4 
RV- , SVC+, SQ+ yes 33.9 19.4 44.0 22.5 
Table 7.1: Relative error (70) (RE) between clinical and model results for con-
figurations with endocardial electrodes in the right ventricle (RV) and superior 
vena cava (SVC) and an apical subcutaneous patch (SQ) 
the clinical results is not of great significance in this instance since it was only 
the patients in which an endocardial-only system was unsuccessful that were 
implanted with the subcutaneous patch and it is known that the defibrillation 
thresholds for these patients were higher that average. However, there still 
remains the question of whether myocardial and skeletal muscle anisotropy 




The boundary element model was used to investigate the performance of dif-
ferent electrode configurations. Some configurations investigated were repre-
sentations of commercial defibrillator leads while others were created for use 
with the model. The aim of the investigations was firstly to ensure that it 
was practical to use the model to test different electrode configurations. A 
second aim was to compare the performance of configurations to find the most 
promising for further evaluation in animal or clinical trials. In the sections 
that follow, the electrode configurations that were modelled are described and 
the investigations and results are presented and discussed. 
8.2 Electrode Types 
Transvenous, subcutaneous and epicardial electrodes were modelled. Some of 
the transvenous electrodes were based on Enguard defibrillation leads produced 
by Telectronics. Other transvenous electrodes were longer or shorter than 
the Enguard electrodes and were positioned differently in the venous system. 
Some subcutaneous patch and epicardial electrodes were of similar shape to 
86 
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Figure 8.1: Example of a configuration with endocardial electrodes in the IVC 
and RV 
commercially available items while others were of quite different shapes and 
sizes Figure 8.1 illustrates two transvenous electrodes positioned in the heart 
and venous system. 
From the perspective of modelling for defibrillation purposes, Enguard 
leads were endocardial catheters incorporating a single active braid electrode. 
Of the whole lead, only the electrode braid was actually modelled, the remain-
der of the lead being passive and small and having little effect on the field. The 
braid was 6cm long and 3mm in diameter. The location of the braid relative 
to the electrode tip depended on the model number of the lead. 
Four Enguard leads were modelled. One was a right ventricular lead with a 
tip to braid spacing of lcm. The others were atrial leads with the lead tip fixed 
in the right atrium. One was the standard atrial lead, model number 040-020, 
and this lead had a tip to braid spacing of 8.5cm. The remaining two leads, 
models 040-022 and 040-024, had spacings of 14.5 and 17.5cm, respectively. 
The tip to braid spacing was the main determining factor in locating the braid 
for a given tip location and lead orientation. For standard tip positioning, the 
braid of model 040-020 was in the superior vena cava just above the junction of 
the right atrium, model 040-022 was 6cm higher and model 040-024 was 9cm 
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higher than standard and entered the subclavian vein. The standard position 
of the right ventricular lead was with the tip of the lead at the apex of the 
right ventricle and the braid within the ventricle. Refer to Appendix D for 
further details of Enguard electrodes. 
Subcutaneous patch electrodes, as previously discussed (Section 5.2), were 
represented simply by potentials specified on torso surface elements. Epicardial 
patch electrodes were represented by a region over the epicardium with the 
potential specified on the inner surface of the patch and zero current specified 
normal to the outer surface. The location, size and shape of these regions were 
located by specifying surface elements from the torso mesh. 
8.3 Electrode Configurations Tested 
The electrode configurations tested included various combinations of the avail-
able electrode types. The configurations will be described under the appro-
priate headings below. Before doing so, though, a note regarding terminology. 
For transvenous systems, there was usually an electrode in the right ventricle 
and this was referred to as the cathode. Unless otherwise stated, this was 
a standard Enguard right ventricular electrode. There was also an electrode 
located outside the heart and this was referred to as the anode. 
Transvenous Anode Within the Venous System (TA -VS) 
A number of transvenous electrode configurations were modelled. These con-
sisted of a cathode in the right ventricle and an anode elsewhere in the venous 
system and were labelled as TA-VS configurations. Each anode had the same 
dimensions as the braid of an Enguard atrial lead. The position of the anode 
was different in each configuration and encompassed locations in the subcla-
vian vein, superior vena cava, right atrium and inferior vena cava. A total of 
29 anode positions were used. 
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The anode position of configuration TA-VS 1 corresponded to the standard 
Enguard atrial lead (model number 040-020). This configuration is illustrated 
in Figure 8.2(a) (and also Plate 3). The figure shows an anterior view of 
the heart with some surface elements removed to expose the electrodes. The 
anode positions of configurations TA-VS 2 and TA-VS 3 corresponded to En-
guard atrial leads 040-022 and 040-024. These configurations are illustrated in 
Figures 8.2(c) and 8.2(d), respectively. 
Further configurations had anodes located elsewhere. The anode in the 
example configuration illustrated in Figure 8.2(b) was positioned in the supe-
rior vena cava slightly above the position of the standard anode. Figure 8.3 
illustrates configurations with anodes positioned below the standard anode po-
sition. These electrodes were partly or wholly in the right atrium or inferior 
vena cava. The anode in Figure 8.3(a) just entered the right atrium. The an-
ode in Figure 8.3(b) passed through the right atrium and came relatively close 
to the cathode. The anode in Figure 8.3(c) was partly in the right atrium and 
partly in the inferior vena cava. The anode in Figure 8.3(d) was mostly within 
the inferior vena cava. The anodes in Figures 8.3(e) and 8.3(f) were entirely 
within the inferior vena cava. The anodes shown in Figures 8.2(d) and 8.3(1) 
were at the extreme upper and lower positions considered. 
Transvenous Anode with Subcutaneous Patch(TA-SQ) 
Configurations TA-SQ 1-4 used a subcutaneous patch together with a cathode 
and Enguard anode. The patch had an area of 78cm 2 and was located on the 
left chest wall over the apex of the heart. The patch was configured as a second 
anode in configurations TA-SQ 1-3, in line with normal clinical practice, and 
as a second cathode in configuration TA-SQ 4. 
CHAPTER 8. INVESTIGATIONS 
	
90 
(a) TA-VS 1 (b) 2.5cm above TA-VS 1 




Figure 8.2: Anode at or above the standard position (configuration TA-VS) 
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Figure 8.3: Anode below the standard position (configuration TA-VS) 
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Figure 8.4: Pulmonary artery transvenous electrode (configuration TA-PA) 
Transvenous Anode in the Pulmonary Artery (TA-PA) 
An alternative to the anode being in the venous system was for the anode to 
be located in the pulmonary artery. This configuration, TA-PA, is illustrated 
in Figure 8.4. The anode was positioned mainly in the left branch of the 
pulmonary artery. This was because it would not fit entirely within the main 
artery and also because positioning in the left branch was more favourable 
with regard to the field strength in the left ventricle. 
In configuration TA-PA 1, the standard cathode was used. A subcutaneous 
patch was added as an anode in TA-PA 2 and as a cathode in TA-PA 3. A 
single cathode in the inferior vena cava was used in TA-PA 4. 
Partly Enlarged Cathode (EC) 
A cathode was constructed with one end partly enlarged (Figure 8.5). This 
cathode was used with the standard anode in configuration EC. The cathode 
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_ 
Figure 8.5: Modified transvenous right ventricular electrode (configuration EC) 
was orientated with the enlarged end near the apex of the right ventricle. 
The aim was to reduce the current density near the end of the electrode by 
increasing the electrode size. 
Cathode Length (CL) 
Configuration CL consisted of a standard anode and a cathode which was ei-
ther an extended or shortened version of the standard Enguard cathode (Fig-
ure 8.6). The standard (Figure 8.6(b)), shortest (Figure 8.6(a)), extended 
(Figure 8.6(c)) and longest (Figure 8.6(d)) electrodes are illustrated.. In total, 
16 different cathodes were tested with lengths from 1.5 to 11.0cm. 
Epicardial Patch Pair (EPP) 
Configuration EPP consisted of a pair of epicardial patches constructed over 
the left and right ventricles (Figure 8.7). The size of the patches were 49cm 2 
(left) and 35cm 2 (right). The patches were shaped to ensure a minimum sep-
aration between the patches of 1.5cm. This helped prevent excessively high 
current densities between the edges of the patches. A similar configuration 
was modelled by Kinst et a/.[2]. They used two 32cm 2 patches located over 
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Figure 8.6: Different length right ventricular electrodes (configuration CL) 
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Figure 8.7: Epicardial patch pair (configuration EPP) 
Epicardial Patch and Transvenous Combination (EP-T) 
Six configurations (EP-T) were constructed that used different size epicardial 
patch anodes with a right ventricular cathode. The aim was to reduce wasted 
energy by minimising the non-myocardial tissue between the anode and cath-
ode. 
Configurations EP-T 1-3 used a standard cathode and a single epicardial 
patch. The patches had surface areas of 67, 131 and 220cm 2 , and are illustrated 
in Figures 8.8, 8.9 and 8.11, respectively. The smallest patch only partly 
covered the left and right ventricles (Figure 8.8). The next covered nearly all 
of the ventricles though some of the right side of the heart remained uncovered 
(8.9). The largest patch covered the whole heart (Figure 8.10), except for the 
major vessels. 
Configuration EP-T 4 was similar to EP-T 1 except the cathode in the right 
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Figure 8.8: 67cm2 epicardial patch (configuration EP-T 1) 
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(b) Posterior 
Figure 8.9: 131cm 2 epicardial patch (configuration EP-T 
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(a) Anterior (b) Posterior 
Figure 8.10: 220cm 2 epicardial patch (configuration EP-T 3) 
superior vena cava. Configuration EP-T 5 used a 25cm 2 patch covering some 
of the left ventricle and an enlarged right ventricular electrode (Figure 8.11). 
The aim of using the enlarged electrode was to more effectively sandwich the 
myocardium between the anode and cathode. Although the enlarged ventricu-
lar electrode was modelled as solid, it was envisaged that the electrode would 
actually be constructed as a spring cage or spiral loop to permit normal blood 
flow in the ventricle. The surface of the enlarged electrode was formed by 
shrinking a copy of the endocardium of the right ventricle by approximately 
0.5cm. 
Subcutaneous Patch Location (SQ) 
Four configurations (SQ) with subcutaneous patch anodes were modelled. 
Configuration SQ 1 consisted of an apical subcutaneous patch (Figure 8.12(a)) 
combined with an Enguard anode and a standard Enguard cathode. SQ 2 had 
(d) Posterior (electrodes only) 
(b) Posterior 
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(c) Anterior (electrodes only) 
Figure 8.11: 25cm2 epicardial patch and large (32cm 2) right ventricular elec-
trode (configuration EP- T 5) 
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a sub-apical subcutaneous patch (Figure 8.12(b)) with a standard Enguard 
anode and cathode. SQ 3 used a pectoral subcutaneous patch (Figure 8.12(c)) 
with a standard Enguard cathode (and was similar to an active-can arrange-
ment). SQ 4 used a anterior subcutaneous patch located over the inferior end 
of the sternum (Figure 8.13(a)) with a standard Enguard cathode and a small 
(5cm2 ) epicardial patch on the posterior left ventricle. 
Effect of an Infarct (INF) 
The effect of an infarct on defibrillator performance was also investigated. The 
infarct was positioned over the anterior surface of the left ventricle. Configura-
tion INF 1 consisted of a transvenous cathode and anode (040-020). Configu-
ration INF 2 consisted of the same endocardial pair and a subcutaneous patch. 
These configurations were modelled in both a healthy and an infarcted heart. 
A specific case of an infarct was assumed where a whole region of the infarct 
was deprived of blood, the muscle had all wasted, resulting in dilated cardiac 
myopathy. Therefore the infarct was modelled by reducing the thickness of 
the myocardium and allowing this region to bulge into the lung cavity (Fig-
ures 8.14 and 8.15). The infarcted region was considered electrically passive 
and therefore unable to sustain ventricular fibrillation. Consequently, it was 
unnecessary to apply defibrillation criteria to this region. It should be noted 
that these assumptions would not necessarily be valid for all infarcts, as often 
there may be spared myocardial muscle which may still be in electrical contact 
with the remaining myocardial muscle. 
8.4 Performance Calculations 
The performance of each configuration was ascertained by calculating the 
anode-cathode resistance (R), the voltage and energy required for defibril- 
lation and the corresponding maximum potential gradient in the ventricular 
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(a) Apical (SQ 1) (b) Sub-Apical (SQ 2) 
(c) Pectoral (SQ 3) 
Figure 8.12: Apical, sub-apical and pectoral subcutaneous patch locations (con-
figuration SQ) 
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(a) Subcutaneous patch rela-
tive to the torso 
(b) View from left posterior side show-
ing patches relative to the heart 
Figure 8.13: Left posterior epicardial and anterior subcutaneous patch combi-
nation (configuration SQ 4) 
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(a) Healthy (b) Infarcted 
Figure 8.14: Healthy and infarcted hearts: the infarcted heart was represented 
as having an infarct in the left-anterior wall of the left ventricle resulting in 
myopathy and bulging of the affected region into the lung cavity (configuration 
INF) 
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CD. 
0C)] 
(a) Healthy 	 (b) Infarcted 
Figure 8.15: Slices through healthy and infarcted hearts (configuration INF) 
myocardium. Voltage was the peak anode-cathode voltage (Vpk) and energy 
was the energy dissipated (E). The energy was calculated by assuming the 
applied defibrillation waveform was a monophasic truncated exponential. The 
waveform was assumed to be a generated from a 7ms discharge from a 150 fiF 
capacitor (C). The load resistance was the anode-cathode resistance calculated 
in the model. The anode-cathode voltage Vac was therefore 
Vac = vpk  e -t/RC , 
	 (8.1) 
where t was the time from application of the peak voltage. The energy dissi-
pated was therefore: 





v2 V2k C i 
— e _2t/(Rc)) . dt .  P 
0  
(8.2) 
The peak voltage was determined from the model output. It was assumed 
CHAPTER 8. INVESTIGATIONS 	 104 
that a minimum potential gradient of 5V/cm was required in all parts of the 
ventricular myocardium for successful defibrillation (see Section 2.2 for discus-
sion of this criteria). 
8.5 Results 
The results presented in this section were obtained using the boundary element 
human torso model with the configurations described in Section 8.3. 
Results for variation in transvenous anode position and cathode length are 
presented in graphical form in Figures 8.16 and 8.17. Figure 8.16 plots varia-
tion in the defibrillation parameters resistance, energy and voltage against the 
location of the inferior end of the anode. Regions corresponding to the inferior 
vena cava (IVC), right atrium (RA), superior vena cava (SVC) and subclavian 
vein are marked on the figure, as is the location of the standard anode posi-
tion. Figure 8.17 plots variation in the same defibrillation parameters against 
cathode length. 
Some of the results from the figures and all the results from other con-
figurations are presented in Table 8.1. The table contains details of each 
electrode configuration with corresponding values of resistance between the 
electrodes, electrode voltage, energy dissipated in the torso and the maximum 
voltage gradient in the ventricular myocardium. These values were calculated 
for defibrillation using a 150pF capacitor and a monophasic 7ms pulse with a 
minimum voltage gradient in the ventricular myocardium of 5V/cm. 
Potentials and gradients plotted on the heart surface are presented for some 
configurations. The plots are for an anode-cathode voltage of ±200V. For the 
potential plots, the contour interval is 10V, solid contour lines are negative, 
broken lines are positive and the thick solid line is at a potential of zero. For 
the potential gradient plots, the contour interval is 5V/cm, the thick solid line 
is at a potential gradient of 5V/cm, broken contour lines are higher gradients. 
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Figure 8.17: Configuration CL results showing how the length of the cathode 
in the right ventricle effects defibrillation performance with a standard anode 
in the superior vena cava 
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Config. 	Ventricular Venous 	Subcutaneous 	Epicardial 









Transvenous anode within the venous system (complete results in Figure 8.16): 
TA-VS 1 	Enguard 	040-020 	(Standard Configuration) 	53.7 447 12.4 101.6 
TA-VS 2 	Enguard 040-022 66.8 476 12.8 86.2 
TA-VS 3 	Enguard 040-024 78.4 538 15.1 96.5 
TA-VS 4 	Enguard IVC 	(Optimal Configuration) 45.4 287 5.4 78.0 
Transvenous anode with apical subcutaneous patch: 
TA-SQ 1 	Enguard- 040-020+ 	78+ (Standard plus Patch) 37.8 265 4.8 69.4 
TA-SQ 2 	Enguard- 040-022+ 78+ 42.7 272 4.9 66.9 
TA-SQ 3 	Enguard- 040-024+ 	78+ 45.8 298 5.8 67.4 
TA-SQ 4 	Enguard- 	040-020- 78+ 
Transvenous anode in the pulmonary artery: 
52.7 437 11.9 97.5 
TA-PA 1 	Enguard PA 51.6 405 10.3 44.5 
TA-PA 2 	Enguard- PA+ 	 78+ 37.1 233 3.8 67.0 
TA-PA 3 	Enguard- PA- 78+ 52.5 344 7.4 71.1 
TA-PA 4 	IVC PA 63.3 564 18.4 108.6 
Partly enlarged cathode: 
EC 	Enlarged 040-020 52.7 427 11.4 94.4 
Cathode length: 
CL-refer to Figure 8.16 
Epicardial patch pair: 
EPP 48.7 & 35.0 45.7 313 6.4 149.2 
Kinsta 32 & 32 49 318 6.5 
Epicardial patch and transvenous combination: 
EP-T 1 	Enguard 	 67 20.3 186 2.6 139.5 
EP-T 2 	Enguard 131 15.6 163 2.0 104.1 
EP-T 3 	Enguard 220 13.2 143 1.5 42.6 
EP-T 4 040-020 	 67 50.3 323 6.6 84.1 
EP-T 5 	32cm2 25 46.9 451 13.2 494.4 
Subcutaneous patch location: 
SQ 1 	Enguard+ 040-020 - 	78+ (Sub-apical) 35.2 265 5.0 73.2 
SQ 2 	Enguard 32 (Apical) 72.8 418 9.5 79.4 
SQ 3 	Enguard 73 (Pectoral) 66.2 416 9.8 78.5 
SQ 4 	Enguard 26 	5 (Anterior) 59.7 306 5.6 376.1 
Effect of infarct: 
INF 1 	Enguard 040-020 53.0 424 11.5 96.3 
INF 2 	Enguard- 040-020+ 	78+ 35.9 277 5.3 83.5 
°data from Kinst et al[2] (energy derived assuming 150pF capacitor and 7ms pulse). 
Table 8.1: Results of investigations for different electrode configurations in the 
human torso boundary element model. Results are for the resistance between 
the electrodes, electrode voltage, energy dissipated in the torso and the maxi-
mum voltage gradient in the ventricular myocardium. Results were calculated 
for defibrillation using a 1501tF capacitor and a monophasic 7ms pulse with a 
minimum voltage gradient in the ventricular myocardium of 5V/cm. 
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The region bounded by the thick solid line is at a potential gradient lower than 
that required for successful defibrillation. 
The epicardial potential and gradient distributions for configuration TA-
VS 1 are presented in Figures 8.18 and 8.19, respectively, for TA-VS 3 in 
Figures 8.20 and 8.21, for TA-VS 4 in Figures 8.22 and 8.23, for TA-PA 1 
in Figures 8.26 and 8.27, for TA-SQ 1 in Figures 8.24 and 8.25, for EPP in 
Figures 8.28 and 8.29 and for EP-T 1 in Figures 8.30 and 8.31, 
Plates 4-6 also show results. Plate 4 is for the standard configuration (TA-
VS 1) and shows the potential and the potential gradient on a section through 
the ventricles. Plate 5 is for the same configuration and is a plot of potential 
gradient over the heart surface. Plate 6 is for the standard configuration plus 
apical subcutaneous patch (TA-SQ 1) and shows the potential gradient on a 
section through the torso and through the ventricles. 
8.6 Discussion 
In discussion of the results, a standard electrode configuration will be used as 
a bench-mark for the purpose of making comparisons between configurations. 
The standard configuration configuration used was TA-VS 1, which consisted 
of the standard Enguard cathode in the right ventricle and the standard En-
guard anode in the superior vena cava. Also, it is reiterated that, ideally, 
the maximum voltage gradient should be less than approximately 80V/cm 
to help avoid interference to the electrical responce of the myocardium (see 
Section 2.2). 
Transvenous Anode Within the Venous System (TA -VS) 
The TA-VS configuration used a cathode in the right ventricle with an anode in 
the venous system. The first TA-VS configuration to consider is the standard 
configuration. The minimum potential gradient for this configuration was on 
(b) Anterior 
(c) Left lateral 
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Figure 8.18: Potential distribution, cathode & anode 040-020 (TA-VS 1) 
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(a) Right lateral (b) Anterior 
(c) Left lateral (d) Posterior 
Figure 8.19: Potential gradient distribution, cathode & anode 040-020 (TA-
VS I) 
(b) Anterior 
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Figure 8.22: Potential distribution, cathode & optimal anode in inferior vena 
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Figure 8.23: Potential gradient distribution, cathode & optimal anode in infe-
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Figure 8.24: Potential distribution, cathode, anode 040-020 and apical subcu-
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Figure 8.25: Potential gradient distribution, cathode, anode 040-020 and apical 
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(a) Right lateral 
Figure 8.26: Potential distribution, transvenous cathode and pulmonary artery 
anode (TA-PA 1) 
(b) Anterior 
(c) Left lateral 
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Figure 8.27: Potential gradient distribution, transvenous cathode and pul-
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Figure 8.28: Potential distribution, epicardial patch pair (EPP) 
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Figure 8.29: Potential gradient distribution, epicardial patch pair (EPP) 
(b) Anterior 
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Figure 8.30: Potential distribution, transvenous cathode and epicardial patch 
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Figure 8.31: Potential gradient distribution, transvenous cathode and epicardial 
patch anode (EP-T 1) 
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the left lateral wall of the left ventricle within the low-gradient region bounded 
by the thick black line in Figure 8.19. 
The performance of other TA-VS configurations can be compared to the 
standard configuration. In general, voltage and energy increased for configu-
rations with the anode higher in the superior vena cava or in the subclavian 
vein. Configuration TA-VS 3, for example, had the anode entering the sub-
clavian vein. Comparing results for this configuration (Figures 8.20 and 8.21) 
with those for the standard configuration (Figures 8.18 and 8.19), the iso-
potential lines are further apart and the low-gradient region was much bigger 
and, although not ascertainable from the figure, had a smaller minimum value. 
Near the standard anode position, though, the trend for increasing voltage 
and energy was interrupted by a local minimum. This coincided with the 
anode being adjacent to the aorta, which provided a low-resistance pathway 
for current flow to the left side of the heart. 
For the anode positioned below the standard position, the voltage and 
energy reduced, and this trend continued until the anode had passed through 
the right atrium and well into the inferior vena cava. It was not until the anode 
was well inferior of the heart that the voltage and energy again increased. 
From observation of Figure 8.16, the best transvenous anode position was 
with the anode in the inferior vena cava. For this configuration, the region of 
low potential gradient was on the upper region of the heart opposite the elec-
trodes (Figure 8.23). Raising the electrode voltage (from 200V) a relatively 
small amount was sufficient to move this region off the heart completely. In this 
position, the voltage and energy were reduced by 35% and 55%, respectively, 
compared to the results using the standard anode position. Significantly, this 
improvement would be achieved simply by using a longer lead to allow posi-
tioning of the the anode in the inferior vena cava. Also, the maximum voltage 
gradient was acceptable and was 23% lower than for the standard configura-
tion. 
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Transvenous Anode with Subcutaneous Patch (TA -SQ) 
The addition of a subcutaneous patch improved the performance of transve-
nous configurations with an anode in the superior vena cava. Reductions in 
voltage, energy and maximum gradient of up to 41%, 61% and 34%, respec-
tively, were achieved compared to the standard configuration. A significant 
lowering of voltage and energy was achieved because the patch increased the 
strength of the field in the left ventricular wall (Figures 8.24 and 8.25), which 
was formerly the lowest gradient region in the ventricular myocardium. These 
configurations were relatively insensitive to the position of the anode. The 
decrease in resistance associated with the addition of the subcutaneous patch 
was due to the improved positioning and increased area of the anodal elec-
trodes. The decrease in maximum gradient was due primarily to the decrease 
in electrode voltage. The use of reversed polarity on the transvenous anode 
(TA-SQ 4) resulted in much worse performance, though still marginally better 
than the standard configuration. The added complexity of the third electrode 
was a disadvantage compared to the standard configuration. 
Transvenous Anode in the Pulmonary Artery (TA -PA) 
Location of the anode in the pulmonary artery (TA-PA 1) decreased the re-
quired voltage and energy by 9% and 17%, respectively, compared to the 
standard configuration. This improvement resulted from the anode in the 
pulmonary artery being better located with respect to the left ventricle than 
for the standard configuration. This increased the voltage gradient through-
out the left ventricle resulting in a smaller sub-threshold region (Figures 8.26 
and 8.27). A significant advantage of this configuration was the low value of 
maximum gradient, which was 56% less than for the standard configuration. 
With a subcutaneous patch added to the configuration (TA-PA 2), an im-
provement in voltage and energy of 12% and 21%, respectively, was achieved 
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compared to the standard configuration with the same patch (TA-SQ 1). This 
significant improvement was again due to the improved field strength in the 
left ventricle. The maximum gradient was similar to that obtained using the 
standard configuration. 
Partly Enlarged Cathode (EC) 
The partly enlarged cathode (EC) decreased defibrillation voltage, energy and 
maximum gradient by 4.5%, 8% and 7%, respectively, compared to the stan-
dard configuration. Although the increase in effectiveness was relatively small, 
it was achieved with only minor modification to the shape of one electrode. 
Cathode Length (CL) 
The results from varying the length of the cathode, from Figure 8.17, indi-
cate that there is an optimum length of approximately 60mm where both the 
voltage and energy are at a minimum. With a longer cathode, more current 
is shunted between the electrodes, reducing their efficiency. With a shorter 
cathode, the voltage gradient is high near the cathode, again reducing the effi-
ciency. For short cathodes, the field is improved if the cathode is moved as far 
as possible towards the apex of the right ventricle, rather than remaining near 
the middle of the ventricle. However, this results in high potential gradients 
in the myocardium near the electrode. 
Epicardial Patch Pair (EPP) 
With a pair of epicardial patches, the potential and potential gradient fields 
(Figures 8.28 and 8.29) were very different to the transvenous configurations. 
Compared to the standard configuration, voltage and energy were reduced 
by 30% and 48%, respectively. The significant reductions may be attributed 
in part to lower resistance and an improved distribution of the electric field. 
However, the maximum gradient increased by 47%. Results for this config- 
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uration were in excellent agreement with those obtained from the model of 
Kinst et a/.[2] (refer to Table 8.1). Agreement between the models was within 
2% for both voltage and energy. This configuration is disadvantaged by the 
requirement for major surgery for patch implantation. 
Epicardial Patch and Transvenous Combination (EP -T) 
The combination of an epicardial patch with a transvenous electrode (EP-T) 
was particularly effective. For the first three configurations, a strong field was 
achieved even with the smallest patch (Figures 8.30 and 8.31). Reductions in 
voltage and energy of up to 59% and 79%, respectively, were achieved compared 
to the standard transvenous configuration. The maximum gradient increased 
by 37% to an unacceptably high value for the smallest patch but decreased by 
85% for the largest. 
The use of the standard anode with the small patch (EP-T 4) gave accept-
able results. This contrasted to the poor results, especially the high maximum 
gradient, from use of a large right ventricular electrode with the small epicar-
dial patch (EP-T 5). 
The best results for this configuration were for a cathode in the right ven-
tricle and a large epicardial patch anode (EP-T 3). This concentrated the field 
in the heart. An advantage of this configuration was the use of only one epi-
cardial patch. The exact positioning of the patch was not critical, unlike with 
a pair of patches where care must be taken to ensure correct spacing between 
the edges of the patches. Use of only one patch may assist implantation of the 
system without thoracotomy. 
Care is taken to avoid covering the main coronary arteries when implant-
ing epicardial patches, due to complications that can arise if the arteries are 
covered by the patches. This issue was not addressed when considering the 
epicardial configurations. However, patches shown as solid and continuous 
may instead be constructed in a piecewise fashion, thereby avoiding covering 
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the arteries. 
Subcutaneous Patch Location (SQ) 
The use of a sub-apical (SQ 1), rather than an apical (TA-SQ 1), subcuta-
neous patch resulted in unchanged voltage, a marginal increase in energy and 
maximum gradient and a small reduction in resistance. This indicated that 
the exact position of the apical patch has little effect on performance. 
In contrast, use of a smaller patch with only a cathode (SQ 2) resulted in 
the voltage and energy increasing by 58% and 98%, respectively, compared to 
the standard transvenous plus patch configuration (TA-SQ 1), illustrating the 
importance of the transvenous anode. Compared to the standard transvenous-
only configuration (TA-VS 1), voltage and energy reduced by 6.5% and 26%, 
respectively, indicating a small improvement in performance for electrodes 
placed either side of the left ventricle rather than in the right ventricle and the 
superior vena cava. 
Use of a pectoral patch with only a cathode (SQ 3), gave similar results 
to SQ 2. Increased resistance, and consequently increased voltage and energy, 
may have been expected compared to the standard configuration because of the 
increased separation of cathode and anode. However, this effect was counter-
acted by the large area of the pectoral patch relative to the standard transve-
nous anode. 
Use of an anterior subcutaneous and a small epicardial patch with a stan-
dard cathode (configuration SQ 4) resulted in generally improved performance 
over the two-electrode apical and pectoral configurations (SQ 1 and 2), but 
worse performance than the standard three-electrode configuration (TA-SQ 1). 
The epicardial patch was too small to generate a sufficiently uniform field in 
the left ventricle, though the subcutaneous patch over the sternum generated 
a strong field in the right ventricle. A major disadvantage was the maximum 
gradient in the myocardium was unacceptably high. 
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Effect of an Infarct (INF) 
With the standard electrode configuration, the effect of an infarct (INF 1) 
was to reduce the voltage and energy for defibrillation by 5% and 7%, re-
spectively. The main reason for the reduction was that the infarct was in the 
lowest gradient region of the ventricles and the gradient in this region could 
be sub-threshold. Therefore, a lower electrode voltage could be used. For this 
configuration, the shape of the electric field was little changed by the bulge of 
the infarcted region. 
With an apical subcutaneous patch (INF 2), the opposite result was found. 
There was now an increase in voltage and energy of 5% and 10%, respectively, 
compared to the standard transvenous plus patch configuration. The main 
reason for this was the bulging wall of the left ventricle displaced some of the 
lung tissue from between the heart and the patch. This resulted in a shunting 
of current through this region and a less favourable electric field in the posterior 
lateral wall of the left ventricle. 
The reason for the good performance of configurations such as EP-T was 
that the myocardium was sandwiched between electrodes that were closely 
spaced, had a large surface-area and wasted little voltage and energy outside 
the heart. The potential effectiveness of this type of configuration can be shown 
by the simple one dimensional example illustrated in figure 8.32. Part (a) 
shows the myocardium sandwiched between two electrodes and part (b) shows 
the same configuration with additional thoracic tissue between the electrodes. 
Expressions for the voltage and energy for successful defibrillation for these 
configurations are as follows: 
VE = qtd, (Rm R°) 
Rni 
(8.3) 










Figure 8.32: (a) efficient 'myocardial sandwich' configuration where the voltage 
and energy is dissipated entirely within the myocardium (b) less efficient stan-
dard configuration with additional voltage and energy dissipation within other 
parts of the thorax 
and 
	





(Rm + ROC) 	
(8.4) 
where VE is the anode-cathode voltage, E is the energy dissipated for a monopha-
sic truncated decaying exponential waveform with an peak voltage V , duration 
t and time-constant dependent on the anode-cathode resistance R and the ca-
pacitance C. Subscripts m and o designate myocardium and other thoracic 
elements, respectively, qt is the defibrillation voltage gradient threshold, and d 
is the region thickness. Of course, minimum voltage and energy are obtained 
when there is only myocardium between the electrodes (i.e. R, = 0). This 
is a theoretical minimum that can not be reduced and is dependent on the 
thickness and conductivity of the myocardium. In practical electrode config-
urations, there would usually at least be some of the left ventricular blood as 
well as myocardium between the electrodes. 
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8.7 Conclusion 
The ability to control the variables in the model allowed investigations to be 
done where direct comparisons of electrode configurations were made. The 
results of these investigations clearly differentiated the performance of each 
configuration and allowed conclusions to be drawn regarding the relative merits 
of each. Such a controlled comparison between many electrode configurations 
would have been very difficult, if not virtually impossible to do experimentally 
and illustrates some of the benefits of modelling. 
Chapter 9 
Conclusion 
The aim of this thesis was to model the electric field from implantable defibril-
lators. It was intended that the capabilities and performance of the methods 
used would be such that it would be possible to model realistic electrode con-
figurations and realistic torso structures. It was desirable that the solution 
speed would be sufficient to enable optimisation of electrode position in a 
torso within a practical time period. 
A brief biomedical background was presented which discussed the heart 
structure, the nature of fibrillation and defibrillation and defibrillators. The 
most important conclusions from this chapter include the following. First, that 
the ventricular myocardium is electrically isolated from the atrial myocardium, 
which means that defibrillation of the ventricles alone is sufficient to ensure 
defibrillation success. Second, that a minimum shock strength through all 
or a critical mass of the ventricles is an effective criteria to apply to assess 
the success or failure of defibrillation. Third, that there is a maximum shock 
strength above which fibrillation may be reinduced. 
Relevant modelling literature was discussed. Most of the models in the 
literature were finite element models and were subject to both the advantages 
and disadvantages of this method. The main advantage was the ability to 
include detailed anisotropy. The main disadvantage was the complex mesh 
131 
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required for each configuration and the amount of computation required for 
electrode optimisation. 
The numerical methods used were presented. The mathematical basis of 
the model was Laplace's equation and this was solved using the boundary 
element method. Constant quadrilateral elements were used. The method 
involved calculation of boundary potentials and normal gradients and then 
post-processing to find internal potentials and gradients. The potential gradi-
ent on boundaries was approximated by linearly interpolating element nodal 
potentials. A finite element model was also developed using the commercial 
package FIDAP. Linear brick elements with 8 nodes were used in this model. 
The implementation of the boundary element method involved constructing 
the torso geometry, specifying boundary conditions and electrodes, building 
the governing matrix equations, solving the equations and performing post-
processing calculations. Torso construction involved manual digitisation of 
CT or MRI scans followed by mesh generation using semi-automatic and man-
ual methods. This procedure resulted in adequate representation of the torso 
structures but would be impractical for generation of a large number of torsos. 
Once the torso was constructed, it was a relatively simple matter to specify 
the boundary conditions and electrodes. Following this, the governing ma-
trix equations were built then solved. This was a time-consuming task and 
typically took approximately 69 hours on a Silicon Graphics Iris Indigo. Effi-
cient out-of-core techniques were developed to enable solution of the matrices, 
which typically contained more than 500 mega-bytes of non-zero values. A 
technique was also developed that allowed electrode configurations to be op-
timised without the need to repeat all the calculations. Solutions to modified 
configurations only took approximately 2 hours to solve. This was a major 
advantage of the method used. 
The numerical methods were validated against analytical and finite element 
models. The results of the validations indicated the numerical methods were 
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accurate and the implementation had been performed correctly. Next, model 
results were validated against measured results on sheep and humans. The 
field magnitudes in the sheep compared well with that predicted by the model 
and the electrode resistance and voltage required for defibrillation predicted 
by the model compared well with those measured in humans. 
A number of investigations were performed using the boundary element 
model with various electrode configurations. Results were visualised over sur-
faces in the model and on slices through regions. Results were presented as 
values of defibrillation voltage, energy, inter-electrode resistance and maximum 
potential gradient. Some configurations required significantly lower voltage 
and energy for defibrillation than configurations in current use. It was found 
that because the variables in the model could be controlled, direct comparisons 
of electrode configurations could be made. The results of these investigations 
clearly differentiated the performance of each configuration and allowed con-
clusions to be drawn regarding the relative merits of each. Such a controlled 
comparison between many electrode configurations would have been difficult, 
if not virtually impossible to do experimentally and illustrated the benefits of 
modelling. In particular, a new transvenous configuration with one electrode 
in the right ventricle and one in the inferior vena cava was found to be a sig-
nificant improvement over current configurations and may be clinically useful. 
Other configurations, some less practical than this, were found to significantly 
reduce defibrillation thresholds. Configurations with a transvenous electrode 
in the right ventricle and a large epicardial patch performed particularly well. 
The factors affecting reduction of voltage and energy were discussed, includ-
ing the limit to reductions. The conclusion was obtained that configurations 
that sandwiched the myocardium between two electrodes produced the lowest 
voltage and energy. This was confirmed by results from modelling this type of 
configuration. 
The advantages of using the boundary element method rather than a purely 
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domain based method included discretisation using surface rather than volume 
elements, ease of modification of the discretised torso, attainment of accurate 
values of potentials and gradients for many configurations without requiring 
extensive re-meshing or mesh refinement, even in regions with relatively large 
potential gradients, and the avoidance of iterative methods and the associated 
convergence issues. One of the biggest advantages was that when electrode 
configurations were modified and the field re-solved, only a relatively small 
amount of re-computation was required. The main disadvantage of using the 
boundary element method was the difficulty of incorporating anisotropy. 
In conclusion, the boundary element model was successful in modelling the 
electric field in the torso and in predicting implantable defibrillator perfor-
mance. The model has potential to be used in research and development and 
in clinical settings. 
Future Work 
There are a number of developments that can be considered for future work. 
One is the inclusion of anisotropic conductivity in the boundary element model. 
In regard to implantable defibrillators, the anisotropy of only two torso re-
gions is significant. Those regions are the myocardium and the skeletal muscle 
layer. Adding anisotropy would represent these areas more accurately. The 
advantages of the boundary element method would be maintained in the other 
regions. 
Two possible methods of including anisotropy are as follows. The anisotropic 
regions could be split into relatively small boundary element regions. Anisotropy 
in each region would be forced to be constant in direction relative to the torso 
axes, because of inherent restrictions in the boundary element method. There-
fore, many small regions would be needed to adequately represent continuously 
varying anisotropy. The numerical methods would need to be modified to al-
low for these additional regions. Alternatively, the boundary element model 
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could be modified so that the anisotropic regions were represented by finite el-
ements. The numerical methods would be modified to combine the boundary 
and finite element methods in the isotropic and anisotropic regions. Methods 
of combining the boundary and finite element methods are well established 
(see, for example, [144, 85]). 
Anisotropy was actually added to the ventricular myocardium in the finite 
element human torso model. Unfortunately, though, numerical results were 
not obtained from this model due to unforeseen difficulties with the imple-
mentation of anisotropy in the FIDAP solver. Therefore this work was not 
presented in this thesis. However, the methods of including anisotropy may 
be used in future work and are as follows. The myocardium was considered to 
be formed from fibres of tissue constructed in spiral formations and forming 
sheets running parallel to the endo- and epicardium. The resistivity of the 
myocardium was assumed to be 2, 5, and 12.511m in the fibre, sheet and cross-
sheet directions, respectively, from published values. As an approximation, 
isotropy was assumed within the sheets (an average of 3.5S1m) and anisotropy 
across the sheets (12.511m) [146]. The direction of anisotropy for each finite 
element was then obtained from the orientation of the nearest segment of the 
epi- or endocardium. 
Apart from inclusion of anisotropy, there are other areas for future work. 
One is the use of high-order boundary elements rather than constant elements. 
High-order elements allow potential and potential gradient to be modelled 
as continuous functions over the boundaries. This would improve the model 
in regard to calculation of boundary gradients. Also, boundaries could be 
modelled as smooth, and fewer elements could be used which may improve the 
speed of solution. 
There are other strategies that could also be used for improving the speed 
of solution. One is to use additional, strategically placed subregions to reduce 
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the size of some of the original regions. Another is to manipulate the governing 
matrix equations further before forming the final matrix equation to give the 
option of calculating potentials and gradients only in the myocardium rather 
than throughout the whole torso. A further strategy would be to represent 
low-conductivity regions such as bone by voids. 
Another area for future work is the development of methods to automate 
torso construction. Automated construction would make the modelling of 
individual patients more practical. One way to build a torso model for a 
patient would be to resize and reshape the boundaries of regions from the 
current torso model to match the boundary positions taken on CT or MRI 
scans, or to match key landmarks from x-ray pictures. Alternatively, image 
processing techniques could be implemented to extract regions from MRI and 
CT scans and this information used to construct the torso. Knowledge of the 
structure of the human body could be used in the process. 
The utility of the model in optimising the electrode configurations in pa-
tients would be improved by addition of some form of automatic optimisation. 
Algorithms used by others ([101, 103], for example) for automatically optimis-
ing electrode position may be suitable for this purpose. 
There is also scope for further validation with improved sheep experiments. 
These experiments may involve using multiple sheep, high resolution scans to 
accurately model torso geometry and locate electrodes and in vivo measure-
ment of tissue conductivity. 
Finally, the model could be used in a number of studies, of which two 
examples are given. One is a parameter sensitivity study to find how the model 
results respond to variations in tissue conductivity and level of anatomical 
detail. This would provide information on the sensitivity and robustness of the 
model to changes in these factors. The other is a study modelling individual 
patients who are to receive an implantable defibrillator. Values of defibrillation 
voltage, energy and resistance could be predicted from the model and compared 
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to values found clinically at the time of implantation from normal testing of 
the defibrillator. Data could be arranged as matched pairs and used for various 
purposes such as model validation, or clinically to predict thresholds or to find 
patients with abnormal results. 
Appendix A 
Detail of the Boundary 
Element Model 
Consider the discretised torso in which the torso tissue, spine, sternum, ribs, 
left and right lungs, heart and arterial and venous blood (T, Sp , St , R, LI, L r , 
H, Bo and By , respectively) are represented as isotropic, homogeneous regions. 
The torso surface consists of the free surface (Ti ) and subcutaneous patch 
electrodes (E3 ). The epicardial surface consists of the free surface (Hh ) and 
epicardial patch electrodes. The insulated outer surface (Eo ) of an epicardial 
patch is a region constructed over the inner surface (Ei), which is part of 
the epicardium. Transvenous electrodes (Es ) are located within the blood. 
Multiple transvenous and epicardial electrodes are indicated by the subscripts 
1 , . . . , n. 
Equation 4.17 is applied in each region in turn resulting in a set of equa-
tions that are combined to form matrix equations A.1 to A.4. The matrix 
notation employed is . The subscript specifies the region and the super-
script specifies the boundary under consideration. 
Torso tissue: the boundaries of this region are the torso surface, heart, spine, 
138 
APPENDIX A. DETAIL OF THE BOUNDARY ELEMENT MODEL 139 
sternum, ribs, lungs. The matrix equation for this region is 














   









   
Spine: the only boundary of this region is the spine. The matrix equation for 
this region is: 
[ H s I U s 	= [ G s: 	Q s: 	(A.2) 
Similar equations to Equation A.2 hold for the sternum, ribs, lungs, and 
arterial blood regions since they also only involve the boundary of one region. 
Heart: the boundaries of this region are the heart, the inner surface of epicar- 
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Venous blood: the boundaries of this region are the venous blood cavities and 
transvenous electrodes. The resulting matrix equation is: 
(A.4)  
The following additional equations describe the compatibility conditions 
on the boundaries. 
Torso-spine interface: 
= uTTSp = rtTSp uTSp U Sp 
QTSp = nTSp = 
_  kT nTSp 	rITSp 
Vs P 	k sP  T = — ICTSp'T 
(A.5)  
1 U11130 = UtilBa = Ura QHBa = Q73 13. _kHB. (21-1.B. (A.6) 
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where ki is the conductivity in region i and the notation ki; denotes k 2 /k. The 
interfaces between the torso and the sternum, ribs and lungs, respectively, were 
similar to Equation A.5. 
Heart and arterial-blood interface: 
The interface between the heart and venous blood was similar to Equation A.6. 
The interface compatibility equations can be substituted into equations A.1,... ,A.4 
to relate each equation through the potential and potential gradient on the re- 
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In this case, UP, UHEs and qv, are known and QT` = Q 0 = 0. Rearranging 
equation A.7 so the unknowns are on the left-hand side and the knowns are on 
the right results in equation A.8, which is in the form of equation 4.20. The 
left hand side matrix of equation A.8 is a square matrix and is known from the 
discretised torso geometry. The right hand side vector is known from the torso 
and electrode geometry and the applied boundary conditions. The vector of 
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Integration over quadrilateral elements was done using two dimensional Gaus-
sian quadrature. The integrals were those in equations (4.12) and (4.13): 
= 	q*dr, 	 (B.1) 
r, 
and 
= 	 (B.2) 
First, basis functions cb i for were defined in terms of dimensionless coordinates 
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The integrals were then transformed from the x, y, z coordinate system to the 
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Note that IGI is the magnitude of the normal vector: 
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g3 = 
IGI =  
(B.11) 
(B.12) 
The integrals of equations (B.1) and (B.2) can now be rewritten 
+1 j+1 
ri q*dr = I 	q*IGIdni dn2 	 (B.13) 
-1 -1 
APPENDIX B. ELEMENT INTEGRALS 	 151 
The geometry for each element was written in terms of the basis functions: 
X =Xi + 02X2 cb3X3 04X4 (B.15) 
Y — Oiyi + 4,2y2 + 153y3 + 04y4 (B.16) 
Z = 	022'2 03z3 04Z4 (B.17)  
and g i ,g2 and g3 found analytically using equation (B.11) while IGI was found 
using equation (B.12). 
The integrals in equations (B.13) and (B.14) can now be evaluated. This 
is done numerically using two dimensional Gaussian quadrature: 
1 P P 
q*clr = —47r E E wmw, r2  IGI m=i 1.1  (B.18)  
and 
u*c/1" = —1 	wmtv/-1 IGI 	 (B.19) 
47r m.11.1 
where 1. is the unit radius vector and 1-1 is the unit surface normal, and Wm  
and tvi are the Gaussian weights for the p integration points. Usually, between 
6 and 12 integration points results in accurate solutions. In the case of the 
singularity, the integration point i was on the element over which integration 
was being done. In this case, the integral in equation (B.13) is zero [144] while 
an accurate calculation for the integral in equation (B.14) is obtained by using 
more integration points than for the non-singular integrations, 24 integration 
points usually being satisfactory. 
Appendix C 
Statistical Definitions 
The correlation coefficient was defined as 
E(xi — Y).(y• - 
CC - 	 
VE(xi -11 2 VE(y i F)2 
(C. 1) 
and the relative error as 







Figure D.1: Eaguard ventricular electrode 
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Figure D.2: Enguard efiltricular electrode-tip detail 
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Figure D.3: Enguard Standard Atrial Lead 040-020 
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Figure D.4: Enguard Atrial Lead 040 - 022 
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Figure D.5: Enguard Atrial Lead 040-024 
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